"id","eudractNumber","randomised","double_blind","therapeutic_area","condition_is_diabetes","subjects_exposed_total","nonserious_ae_count","deaths_total","mortality_percent","condition_text"
"2004-000022-75-ES","2004-000022-75",1,1,"Unknown",0,NA,NA,NA,NA,"Albuminuria in hypertensive subjects at increased cardiovascular risk."
"2004-000086-35-FI","2004-000086-35",1,0,"Unknown",1,NA,NA,NA,NA,"Type 1 diabetes"
"2004-000087-27-FI","2004-000087-27",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes"
"2004-000134-37-IT","2004-000134-37",1,1,"Diseases C - Blood and lymphatic diseases C15",0,NA,NA,NA,NA,"Treatment of anemia in subjects with chronic kidney disease CKD."
"2004-000156-16-ES","2004-000156-16",1,1,"Unknown",0,NA,NA,NA,NA,"Coronary Heart Disease"
"2004-000311-26-IT","2004-000311-26",1,NA,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus"
"2004-000312-93-BE","2004-000312-93",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2004-000313-19-HU","2004-000313-19",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2004-000347-14-BE","2004-000347-14",1,1,"Unknown",1,NA,NA,NA,NA,"Men or women who are 18 years of age or older at the enrolment visit visit 1 diagnosed with type 2 diabetes and treated with diet alone or on treatment with a single oral anti diabetic agent or low doses of two agents."
"2004-000348-25-IT","2004-000348-25",1,1,"Unknown",0,NA,NA,NA,NA,"To prevent vascular disease associated with insulin resistence."
"2004-000349-40-IT","2004-000349-40",1,NA,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2004-000350-24-IT","2004-000350-24",1,1,"Unknown",1,NA,NA,NA,NA,"Tesaglitazar on glycemic control in subject with Type II Diabetes"
"2004-000354-22-ES","2004-000354-22",0,0,"Unknown",0,NA,NA,NA,NA,"Concurrent hypertension and dyslipidaemia Hipertension ICD code 80011/MedDRA: coded under preferred term vascular system disorder, code 10020772 Dyslipidaemia ICD code 89212/MedDRA: coded under preferred term metabolism and nutrition disosrder, code 10058108"
"2004-000376-14-IT","2004-000376-14",1,NA,"Unknown",1,NA,NA,NA,NA,"MONOTHERAPY TREATMENT OF PATIENTS WITH TYPE 2 DIABETES"
"2004-000488-83-ES","2004-000488-83",1,0,"Unknown",0,NA,NA,NA,NA,"Chronic Hepatitis C, Genotype 1"
"2004-000506-52-BE","2004-000506-52",1,1,"Unknown",1,NA,NA,NA,NA,"NIDDM non insulin dependent diabetes mellitus"
"2004-000514-38-IE","2004-000514-38",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes"
"2004-000539-27-ES","2004-000539-27",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes"
"2004-000540-24-ES","2004-000540-24",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2004-000542-20-ES","2004-000542-20",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes"
"2004-000551-42-ES","2004-000551-42",0,0,"Unknown",1,NA,NA,NA,NA,"Neuropata diabtica distal dolorosa Painful distal diabetic neuropathy"
"2004-000558-22-ES","2004-000558-22",0,0,"Unknown",0,107,796,0,0,"Chronic hepatitis C"
"2004-000577-65-FI","2004-000577-65",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2004-000616-70-BE","2004-000616-70",1,0,"Unknown",1,NA,NA,NA,NA,"Type 1 diabetes mellitus"
"2004-000820-34-PT","2004-000820-34",1,0,"Unknown",0,NA,NA,NA,NA,"Chronic Hepatitis C, Genotype 2 or 3"
"2004-000867-92-DE","2004-000867-92",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2004-000960-28-ES","2004-000960-28",0,NA,"Unknown",1,NA,NA,NA,NA,"Painful diabetic neuropathy"
"2004-001033-41-IT","2004-001033-41",1,NA,"Unknown",1,NA,NA,NA,NA,"Therapy of erectile disfunction to subjects with diabetes mellitus and erectile disfunction with a 2.5 mg or 5 mg daily dosing."
"2004-001062-40-ES","2004-001062-40",1,1,"Unknown",1,NA,NA,NA,NA,"Hypertension with diabetes mellitus"
"2004-001144-71-ES","2004-001144-71",1,1,"Diseases C - Cardiovascular Diseases C14",1,NA,NA,NA,NA,"Patients diagnosed with type 2 diabetes and treated with a single or multiple oral antidiabetic agents"
"2004-001220-20-ES","2004-001220-20",0,NA,"Unknown",0,NA,NA,NA,NA,"Chronic Hepatitis C, Genotype 1"
"2004-001252-36-ES","2004-001252-36",1,1,"Unknown",0,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION"
"2004-001258-94-ES","2004-001258-94",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2004-001287-49-ES","2004-001287-49",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus type2"
"2004-001461-18-ES","2004-001461-18",1,NA,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes"
"2004-001546-32-FI","2004-001546-32",1,1,"Unknown",1,NA,NA,NA,NA,"Patients with type 2 diabetes"
"2004-001810-16-BE","2004-001810-16",1,0,"Diseases C - Cancer C04",0,908,1,158,17.4008810572687,"Gastrointestinal stromal tumors GIST are mesenchymal neoplasms usually arising from the gastrointestinal wall.  Pathologically,they present with spindle cells in most cases. Immunohistochemically, GIST cells are almost always positive for CD117.CD117 corresponds to the KIT receptor, a tyrosine kinase receptor which is altered in GIST due to a mutation to the c-kit oncogene.  This event is held to be critical for GIST pathogenesis."
"2004-001959-11-ES","2004-001959-11",1,1,"Unknown",0,NA,NA,NA,NA,"Coronary artery disease"
"2004-001979-18-ES","2004-001979-18",1,1,"Unknown",1,NA,NA,NA,NA,"Tratamiento de la Diabetes Mellitus Tipo 2"
"2004-002007-33-AT","2004-002007-33",1,1,"Unknown",0,NA,NA,NA,NA,"Alzheimer Disease"
"2004-002036-25-BE","2004-002036-25",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2004-002136-25-ES","2004-002136-25",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2004-002159-16-BE","2004-002159-16",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2004-002160-22-ES","2004-002160-22",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus Chronic Renal Insufficiency MedDRA classification code:  10050441"
"2004-002236-26-IT","2004-002236-26",1,NA,"Unknown",0,NA,NA,NA,NA,"Primary Hypercholesterolemia"
"2004-002245-12-DE","2004-002245-12",1,0,"Diseases C - Cancer C04",0,NA,NA,NA,NA,"Uveal melanomas with specific hepatic tropism"
"2004-002267-24-ES","2004-002267-24",1,0,"Unknown",0,NA,NA,NA,NA,"Renal transplantation"
"2004-002466-38-CZ","2004-002466-38",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus"
"2004-002530-20-CZ","2004-002530-20",1,1,"Unknown",1,NA,NA,NA,NA,"Painful diabetic neuropathy"
"2004-002549-11-FI","2004-002549-11",0,0,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes Mellitus"
"2004-002550-56-DE","2004-002550-56",1,1,"Unknown",1,NA,NA,NA,NA,"Men or women diagnosed with type 2 diabetes and treated with diet alone or on treatment with a single oral anti diabetic agent or low doses of two agents, and with diabetic dyslipidaemia ie low HDL-C."
"2004-002644-10-ES","2004-002644-10",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus II"
"2004-002661-21-ES","2004-002661-21",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2004-002731-62-IT","2004-002731-62",1,0,"Unknown",1,NA,NA,NA,NA,"TYPE 2 DIABETES MELLITUS"
"2004-002757-31-SE","2004-002757-31",1,1,"Unknown",0,NA,NA,NA,NA,"Type 2 Dibetes"
"2004-002778-50-BE","2004-002778-50",1,NA,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes"
"2004-002940-82-IT","2004-002940-82",1,NA,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes"
"2004-002974-48-BE","2004-002974-48",1,0,"Unknown",0,539,241,99,18.3673469387755,"TRANSPLANTATION, NOS"
"2004-003000-37-BE","2004-003000-37",1,1,"Unknown",1,NA,NA,NA,NA,"Hypercholesterolemia in patients with Type II Diabetes"
"2004-003840-22-FI","2004-003840-22",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes Mellitus"
"2004-004090-29-ES","2004-004090-29",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"atherosclerosis in Type 2 Diabetes Mellitus patients with cardiovascular disease"
"2004-004094-28-DE","2004-004094-28",1,1,"Unknown",0,NA,NA,NA,NA,"healthy subjects without prior history of MI, stroke or arterial revascularization who, on initial screening, are found to have LDL.C levels below 130 mg/dL 3.36 mmol/L and CRP levels equal to or exceeding 2.0 mg/L"
"2004-004374-90-SE","2004-004374-90",1,1,"Unknown",1,NA,NA,NA,NA,"Men or women who are 18 years of age or more at enrolment visit 1. The patients should be drug-nave with Type 2 diabetes and not on anti-diabetic treatment during the recent 24 weeks."
"2004-004559-21-ES","2004-004559-21",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes Mellitus"
"2004-004696-11-ES","2004-004696-11",0,NA,"Unknown",1,NA,NA,NA,NA,"Moderately severe or severe non-proliferative diabetic retinopathy NPDR or low risk proliferative diabetic retinopathy"
"2004-004794-28-ES","2004-004794-28",1,1,"Unknown",0,NA,NA,NA,NA,"Hypertension"
"2004-004881-34-DE","2004-004881-34",1,1,"Unknown",1,NA,NA,NA,NA,"Patients with Type 2 diabetes not treated by a pharmacological agent."
"2004-004918-17-ES","2004-004918-17",0,0,"Unknown",0,NA,NA,NA,NA,"Alzheimers disease"
"2004-004996-12-BE","2004-004996-12",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetic macular Edema"
"2004-004997-10-IT","2004-004997-10",1,1,"Diseases C - Eye Diseases C11",1,NA,NA,NA,NA,"diabetic macular edema"
"2004-005024-40-DK","2004-005024-40",1,1,"Unknown",1,NA,NA,NA,NA,"Painful Diabetic Neuropathy"
"2004-005045-35-SE","2004-005045-35",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2004-005243-97-BE","2004-005243-97",0,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes Mellitus"
"2005-000093-50-ES","2005-000093-50",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2005-000407-34-NO","2005-000407-34",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2005-000473-22-SK","2005-000473-22",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2005-000517-36-BE","2005-000517-36",NA,0,"Unknown",0,NA,NA,NA,NA,"maintenance of liver transplant"
"2005-000566-40-HU","2005-000566-40",1,0,"Unknown",1,NA,NA,NA,NA,"Patients with type 1 diabetes mellitus and many patients with type 2 diabetes mellitus require daily use of insulin for the maintenance of normal glucose homeostasis.  At present, insulin can be delivered only by injection.  The availability of noninjectable routes of insulin administration may eliminate a barrier to effective therapy and improve the quality of life for many patients with diabetes."
"2005-000715-98-BE","2005-000715-98",1,1,"Unknown",0,NA,NA,NA,NA,"atrial fibrillation/atrial flutter"
"2005-000899-40-IT","2005-000899-40",1,1,"Diseases C - Hormonal diseases C19",1,NA,NA,NA,NA,"previous gestational diabetes GDM and altered glucose metabolism in the post-partum period Impaired Fasting Glucose or Impaired Gluocse Tolerance"
"2005-000900-15-ES","2005-000900-15",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetic Macular Edema DME, is the most common cause of visual impairment in patients with diabetic retinopathy DR. It is the accumulation of extracellular fluid in the retinal tissues of the macula and is a microvascular complication of diabetes. In this study patients will have macular edema that meets the Early Treatment Diabetic Retinopathy Study ETDRS criteria for clinically significant macular edema CSME, but patients with imminently vision threatening macular edema are excluded."
"2005-000904-15-DE","2005-000904-15",1,1,"Unknown",1,NA,NA,NA,NA,"Type 1 diabetes, recently diagnosed"
"2005-000976-42-ES","2005-000976-42",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes"
"2005-001038-34-DE","2005-001038-34",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes Mellitus and Combined Dyslipidemia"
"2005-001059-39-BE","2005-001059-39",1,1,"Unknown",0,18144,1425,672,3.7037037037037,"Primary Hyperlipidermia"
"2005-001373-97-DE","2005-001373-97",0,NA,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes Mellitus"
"2005-001460-32-BE","2005-001460-32",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetic Macular Edema DME"
"2005-001613-17-DE","2005-001613-17",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetic Patients Inadequately Controlled with Insulin"
"2005-002115-24-ES","2005-002115-24",0,0,"Unknown",1,NA,NA,NA,NA,"Diabetes tipo II"
"2005-002199-14-ES","2005-002199-14",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2005-002313-21-DE","2005-002313-21",1,1,"Unknown",0,NA,NA,NA,NA,"Treatment of patients with primary dyslipidaemia currently taking simvastatin 20mg or 40mg"
"2005-002316-24-DE","2005-002316-24",1,1,"Unknown",0,NA,NA,NA,NA,"Treatment of patients with primary dyslipidaemia"
"2005-002546-20-PT","2005-002546-20",1,1,"Diseases C - Cancer C04",0,5752,4273,18,0.312934631432545,"For active immunization of girls and women from 10 years of age onwards for the prevention of persistent human papillomavirus HPV infections and related clinical outcomes cytological abnormalities and pre-cancerous lesions caused by oncogenic HPV types 16 and 18."
"2005-002590-73-ES","2005-002590-73",1,1,"Unknown",1,NA,NA,NA,NA,"Type I Diabetes"
"2005-002607-17-BE","2005-002607-17",1,1,"Unknown",1,NA,NA,NA,NA,"Male hypogonadism is generally characterised by abnormally low serum testosterone levels. Symptoms include changes in mood, decreased bone mineral density, increased body fat, decreased muscle mass and strength and sexual dysfunction. A number of conditions can also be associated with decreased testosterone production including metabolic syndrome, type II diabetes mellitus, atherosclerosis, myocardial infarction and chronic heart failure"
"2005-002765-37-BE","2005-002765-37",1,0,"Diseases C - Cancer C04",0,1946,33,48,2.46659815005139,"Supradiaphragmatic stage I/II Hodgkins lymphoma"
"2005-002778-30-ES","2005-002778-30",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2005-002817-19-BE","2005-002817-19",1,1,"Unknown",0,NA,NA,NA,NA,"Prevention of cytomegalovirus CMV disease in kidney transplant recipients"
"2005-002920-32-DE","2005-002920-32",1,0,"Unknown",0,NA,NA,NA,NA,"prophylaxis of organ rejections in adult patients after liver transplantation"
"2005-002942-20-BE","2005-002942-20",1,1,"Unknown",0,NA,NA,NA,NA,"Patients with abdominal obesity at increased risk for cardiovascular events myocardial infarctio, stroke and cardiovascular death"
"2005-003270-14-DE","2005-003270-14",1,1,"Unknown",0,NA,NA,NA,NA,"Study in patients with mixed dyslipidemia at risk of cardiovascular disease not adequately controlled by 20 mg simvastatin alone"
"2005-003281-41-IE","2005-003281-41",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes Mellitus"
"2005-003414-15-IT","2005-003414-15",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus"
"2005-003415-71-IT","2005-003415-71",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2005-003417-32-BE","2005-003417-32",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus"
"2005-003434-18-BE","2005-003434-18",1,0,"Unknown",0,NA,NA,NA,NA,"Older women 66 years of age or older with histologically proven, resected breast cancer. The disease must be classified as endocrine nonresponsive and patients must not be candidates for endocrine therapy or for an adjuvant chemotherapy program which includes a standard anthracycline-containing chemotherapy regimen."
"2005-003504-11-ES","2005-003504-11",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2005-003714-15-DE","2005-003714-15",1,NA,"Unknown",1,NA,NA,NA,NA,"Es geht um keine therapeutische Fragestellung. In dem geplannten Versuche sollen die Effekte des Glukagons i.m/i.v. auf die GH-, Cortisol-, Insulin-, Glukose-, Ghrelin-, GLP-1-, IGFBP-1- und Katecholamine-Konzentrationen in Gesunden sowie in den Typ 1 Diabetikern untersucht werden."
"2005-003894-26-ES","2005-003894-26",1,1,"Unknown",0,NA,NA,NA,NA,"Prevention of Stroke and Systemic Embolism in patients with Atrial Fibrillation"
"2005-004188-50-DE","2005-004188-50",0,NA,"Unknown",1,NA,NA,NA,NA,"Diabetic Peripheral Neuropathic Pain"
"2005-004250-28-BE","2005-004250-28",1,NA,"Unknown",0,NA,NA,NA,NA,"COMPLICATED SKIN AND SKIN STRUCTURE INFECTION"
"2005-004411-29-DE","2005-004411-29",1,1,"Unknown",0,NA,NA,NA,NA,"Smoking Cessation"
"2005-004598-20-IT","2005-004598-20",1,0,"Unknown",0,NA,NA,NA,NA,"Secondary prevention of myocardial infarction."
"2005-004667-36-ES","2005-004667-36",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus Tipo 2 Type II diabetes mellitus."
"2005-004668-22-ES","2005-004668-22",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus tipo 2 Type II diabetes mellitus."
"2005-004669-40-ES","2005-004669-40",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus tipo 2 Type II diabetes mellitus."
"2005-004670-24-CZ","2005-004670-24",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes mellitus."
"2005-004671-38-ES","2005-004671-38",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus Tipo 2 Type II diabetes mellitus."
"2005-004672-20-CZ","2005-004672-20",1,0,"Unknown",1,NA,NA,NA,NA,"Type II diabetes mellitus."
"2005-004695-20-DE","2005-004695-20",1,0,"Unknown",0,299,66,31,10.3678929765886,"Prevention of cytomegalovirus CMV disease in kidney transplant recipients"
"2005-004798-60-DE","2005-004798-60",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2005-005093-70-ES","2005-005093-70",1,1,"Unknown",0,NA,NA,NA,NA,"Hypercholesterolaemia"
"2005-005378-58-ES","2005-005378-58",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus"
"2005-005448-21-ES","2005-005448-21",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus tipo 2"
"2005-005749-20-HU","2005-005749-20",0,NA,"Unknown",0,NA,NA,NA,NA,"essentialis hypertnia"
"2005-005788-27-ES","2005-005788-27",1,1,"Unknown",1,NA,NA,NA,NA,"Neuropata diabtica distal dolorosa Painful distal diabetic neuropathy"
"2005-006041-16-DE","2005-006041-16",1,1,"Unknown",1,NA,NA,NA,NA,"Combined Dyslipidemia and Type II Diabetes Mellitus"
"2005-006060-63-DE","2005-006060-63",1,1,"Unknown",1,NA,NA,NA,NA,"Patients with type 2 diabetes mellitus and dyslipidemia"
"2005-006164-59-GB","2005-006164-59",1,NA,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes"
"2006-000006-23-DE","2006-000006-23",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2006-000051-18-FR","2006-000051-18",1,0,"Unknown",1,347,16,0,0,"Type I Diabetes"
"2006-000192-14-ES","2006-000192-14",1,1,"Unknown",0,NA,NA,NA,NA,"Subjects with coronary atherosclerosis who require PCI with or without stent. Sujetos con ateroesclerosis coronaria que precisan una ICP con o sin stent"
"2006-000247-26-ES","2006-000247-26",1,NA,"Unknown",1,NA,NA,NA,NA,"Diabetes Tipo 2 Este estudio paralelo incluye 3 grupos de tratamiento: pacientes que siguen con un rgimen intensificado de insulina glargina, pacientes que interrumpen la insulina glargina una vez al da e inician la IHPI con las comidas y pacientes que continan con la insulina glargina una vez al da, pero aaden IHPI con las comidas."
"2006-000497-80-BE","2006-000497-80",1,NA,"Unknown",1,NA,NA,NA,NA,"Male or female nonsmoking patients 18 years of age or older who have had type 1 diabetes mellitus for at least 24 months at study entry and are taking at least 2 or 3 preprandial injections per day for at least 2 months, have FEV1 and DLCO 70 predicted, and have an HbA1c less or equal 11.0 at screening."
"2006-000515-15-GR","2006-000515-15",1,1,"Unknown",0,NA,NA,NA,NA,"Study in patients with mixed dyslipidemia at risk of cardiovascular disease not adequately controlled by 40 mg pravastatin alone."
"2006-000519-21-DE","2006-000519-21",1,1,"Unknown",0,NA,NA,NA,NA,"Study in patients with mixed dyslipidemia at risk of cardiovascular disease not adequately controlled by 10 mg atorvastatin alone"
"2006-000658-27-BE","2006-000658-27",1,1,"Unknown",0,NA,NA,NA,NA,"non-ST and ST elevation acute coronary syndromes ACS"
"2006-000694-30-EE","2006-000694-30",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes Mellitus"
"2006-000725-54-IT","2006-000725-54",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes and metabolic syndrome  IDF definition"
"2006-000796-15-ES","2006-000796-15",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes tipo 2"
"2006-000924-15-DE","2006-000924-15",1,1,"Unknown",1,NA,NA,NA,NA,"Patients with type 2 diabetes mellitus and dyslipidemia not appropriately controlled with a statin"
"2006-001138-42-ES","2006-001138-42",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes"
"2006-001218-34-SE","2006-001218-34",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2006-001219-31-DE","2006-001219-31",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2006-001240-30-BE","2006-001240-30",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus non insulino dependant"
"2006-001246-13-ES","2006-001246-13",1,1,"Unknown",0,NA,NA,NA,NA,"Locally advanced or metastatic renal clear cell adenocarcinoma"
"2006-001335-22-IT","2006-001335-22",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes mellitus"
"2006-001392-37-AT","2006-001392-37",1,1,"Unknown",1,NA,NA,NA,NA,"type 2 diabetes mellitus"
"2006-001598-10-GB","2006-001598-10",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetic Neuropathy"
"2006-001599-18-BE","2006-001599-18",1,1,"Unknown",0,NA,NA,NA,NA,"complicated skin and skin structure Infections"
"2006-001885-17-DK","2006-001885-17",1,1,"Unknown",1,NA,NA,NA,NA,"Cardiovascular disease: History of myocardial infarction or cerebrovascular atherosclerotic disease history of presumed ischaemic stroke, transient ischaemic attack or carotid revascularisation or peripheral arterial disease i.e. intermittent claudication or history of revascularisation or diabetes mellitus with any of the above or with other evidence of symptomatic coronary heart disease."
"2006-001898-25-ES","2006-001898-25",1,1,"Unknown",0,NA,NA,NA,NA,"Resistant hypertension La hipertensin arterial resistente"
"2006-002147-91-BE","2006-002147-91",1,1,"Unknown",0,NA,NA,NA,NA,"ARRHYTHMIA THROMBOSIS"
"2006-002257-76-BE","2006-002257-76",1,1,"Unknown",1,NA,NA,NA,NA,"Subjects with diabetes with a qualifying foot infection."
"2006-002271-41-DE","2006-002271-41",1,1,"Unknown",1,NA,NA,NA,NA,"Patients with Type 2 Diabetes mellitus and HbA1c  6,5, but  8,5 and/ or fasting plasma glucose  7 mmol/l will be eligible for the study"
"2006-002466-19-ES","2006-002466-19",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes tipo 2"
"2006-002478-23-FR","2006-002478-23",0,0,"Unknown",1,146,232,0,0,"Type 1 Diabetes"
"2006-002488-20-IT","2006-002488-20",1,1,"Unknown",1,NA,NA,NA,NA,"diabetes"
"2006-002616-96-ES","2006-002616-96",1,1,"Unknown",0,349,12,0,0,"Hipercolesterolemia familiar heterocigota HFHe"
"2006-002794-51-DE","2006-002794-51",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2006-002809-31-BE","2006-002809-31",1,1,"Unknown",0,NA,NA,NA,NA,"Acute Coronary Syndrome"
"2006-002848-28-FR","2006-002848-28",1,0,"Unknown",1,NA,NA,NA,NA,"Patients with type 2 diabetes T2DM and dyslipidemia."
"2006-002951-33-ES","2006-002951-33",1,1,"Body processes G - Metabolic Phenomena G03",1,NA,NA,NA,NA,"Patients with abdominal obesity, with type 2 diabetes mellitus or dyslipidaemia, with or without other cardiometabolic risk factors."
"2006-002999-17-BE","2006-002999-17",1,0,"Unknown",1,NA,NA,NA,NA,"Male or non pregnant female nonsmoking patients, 18 years of age or older: have had type 2 diabetes mellitus for at least 6 months, and have been treated with one or more oral antihyperglycemic medications for at least 6 weeks 12 weeks for thiazolidinediones TZDs, and are insulin-nave as defined in the protocol, have HbA1c 7.0 and 10.5, and FEV1 and DLCO 70 of predicted value"
"2006-003107-39-DE","2006-003107-39",1,1,"Unknown",0,NA,NA,NA,NA,"Hypercholesterolemia"
"2006-003132-29-BE","2006-003132-29",1,0,"Unknown",1,NA,NA,NA,NA,"postherpetic neuralgia and painful diabetic polyneuropathy"
"2006-003547-23-BE","2006-003547-23",1,1,"Unknown",0,NA,NA,NA,NA,"Resistant hypertension"
"2006-003604-19-BE","2006-003604-19",1,1,"Unknown",0,NA,NA,NA,NA,"ULCERATIVE COLITIS,NOS"
"2006-003771-12-DE","2006-003771-12",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2006-003935-56-ES","2006-003935-56",1,1,"Unknown",0,NA,NA,NA,NA,"Subjects with coronary atherosclerosis excluding ST segment-elevation MI STEMI who require PCI with or without stent. Sujetos con ateroesclerosis coronaria excluyendo el IM por elevacin del segmento ST STEMI que necesiten una ICP con o sin endoprtesis vascular Stent"
"2006-004111-22-BE","2006-004111-22",1,1,"Unknown",0,162,6,0,0,"Cushings disease is rare disease that is caused by an adrenocorticotropic hormone ACTH secreting pituitary adenoma. The elevated ACTH secreted by these tumors stimulates the adrenal glands to produce excess cortisol, leading to the subsequent development of the clinical signs and symptoms of hypercortisolism. Cushings disease is associated with severe morbidity and premature mortality and most commonly affects adults aged 20-50, primarily females"
"2006-004455-37-DE","2006-004455-37",1,1,"Unknown",1,NA,NA,NA,NA,"Patients with Type 2 Diabetes mellitus HbA1c  6.5 and /  9 and diabetic dylipidemia inefficiently treated with Metformin monotherapy maximal individually tolerated dose will be eligible for this trial."
"2006-004467-65-DE","2006-004467-65",1,1,"Unknown",1,NA,NA,NA,NA,"nephropathy after renal transplantation in patients with type 2 diabetes"
"2006-004595-13-BE","2006-004595-13",1,1,"Unknown",0,NA,NA,NA,NA,"Prevention of Stroke and Non-CNS Systemic Embolism in Non-Valvular Atrial Fibrillation"
"2006-004623-12-BE","2006-004623-12",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes"
"2006-004702-56-ES","2006-004702-56",1,1,"Unknown",0,NA,NA,NA,NA,"Adult Patients in Chronic  Dialysis APCD  Pacientes Adultos en Dilisis Crnica PADC"
"2006-004733-15-DE","2006-004733-15",1,1,"Unknown",1,NA,NA,NA,NA,"Type I diabetes"
"2006-004861-33-ES","2006-004861-33",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes tipo 1"
"2006-004888-54-ES","2006-004888-54",1,1,"Unknown",0,NA,NA,NA,NA,"Enfermedad de Alzheimer Alzheimers Disease"
"2006-004942-18-BE","2006-004942-18",1,1,"Unknown",0,NA,NA,NA,NA,"sleep maintenance insomnia"
"2006-005047-28-DE","2006-005047-28",1,1,"Unknown",1,NA,NA,NA,NA,"The current study will support an indication for rivoglitazone as oral monotherapy to improve glycemic control in subjects with type 2 diabetes mellitus not adequately controlled with diet and exercise alone."
"2006-005051-15-BE","2006-005051-15",1,1,"Unknown",1,NA,NA,NA,NA,"type II Diabetes mellitus"
"2006-005101-64-IT","2006-005101-64",1,1,"Unknown",1,NA,NA,NA,NA,"type 2 diabetes"
"2006-005192-18-DE","2006-005192-18",1,1,"Unknown",0,NA,NA,NA,NA,"Obesity"
"2006-005283-47-DE","2006-005283-47",1,1,"Unknown",0,NA,NA,NA,NA,"Complicated Skin and Skin Structure Infections cSSSI"
"2006-005332-25-DE","2006-005332-25",1,1,"Unknown",0,NA,NA,NA,NA,"Complicated Skin and Skin Structure Infections cSSSI"
"2006-005383-51-ES","2006-005383-51",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type II diabetes"
"2006-005385-39-ES","2006-005385-39",1,1,"Unknown",1,NA,NA,NA,NA,"Overweight/Obese Type 2 Diabetic Patients Not Adequately Controlled with Metformin ----------------------------- Pacientes diabticos tipo 2 con sobrepeso/obesos no adecuadamente controlados con metformina."
"2006-005492-17-HU","2006-005492-17",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2006-005851-14-EE","2006-005851-14",1,1,"Unknown",0,NA,NA,NA,NA,"Study in patients with mixed dyslipidemia type IIb at risk of cardiovascular disease not adequately controlled by 40 mg simvastatin alone."
"2006-005931-56-CZ","2006-005931-56",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes mellitus"
"2006-005951-14-IT","2006-005951-14",1,0,"Unknown",1,103,8,10,9.70873786407767,"Diabetic nephropathy"
"2006-005954-62-IT","2006-005954-62",1,0,"Unknown",1,612,67,16,2.61437908496732,"Diabetic nephropathy"
"2006-005969-18-ES","2006-005969-18",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes Type II"
"2006-006025-73-BE","2006-006025-73",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes Mellitus"
"2006-006092-21-ES","2006-006092-21",1,0,"Unknown",1,NA,NA,NA,NA,"diabetes tipo 2"
"2006-006149-15-IT","2006-006149-15",0,0,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes"
"2006-006437-40-BE","2006-006437-40",1,0,"Unknown",0,NA,NA,NA,NA,"HIV-1"
"2006-006488-22-DE","2006-006488-22",1,1,"Unknown",1,NA,NA,NA,NA,"Painful Diabetic Neuropathy"
"2006-006550-96-DE","2006-006550-96",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,572,129,0,0,"Oral insulin is to be used for the prevention of type 1 diabetes mellitus in relatives at risk of developing the disease."
"2006-006677-25-FR","2006-006677-25",1,1,"Unknown",1,NA,NA,NA,NA,"Sleep maintenance insomnia + subpopulation of stable type II Diabetes Mellitus"
"2006-006754-10-FR","2006-006754-10",NA,NA,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus non insulino dependant"
"2006-006967-22-ES","2006-006967-22",1,0,"Unknown",0,NA,NA,NA,NA,"Subjects 18  65 years of age, who meets the DSM-IV criteria for schizophrenia with a PANSS total score at screening of 60-100 inclusive, and who in the opinion of the investigator will benefit from a treatment with paliperidone ER or olanzapine"
"2007-000019-27-ES","2007-000019-27",1,1,"Unknown",1,NA,NA,NA,NA,"type II diabetes mellitus"
"2007-000037-19-ES","2007-000037-19",1,1,"Unknown",0,NA,NA,NA,NA,"Mixed Hyperlipidemia Hiperlipidemia Mixta"
"2007-000145-35-ES","2007-000145-35",1,1,"Unknown",1,NA,NA,NA,NA,"type II diabetes mellitus Diabetes Mellitus Tipo II"
"2007-000208-34-BE","2007-000208-34",1,0,"Diseases C - Cancer C04",0,1672,300,36,2.15311004784689,"Adult patients with newly diagnosed Philadelphia chromosome positive Ph+ chronic myelogenous leukemia in chronic phase CML-CP"
"2007-000236-16-EE","2007-000236-16",1,1,"Unknown",0,NA,NA,NA,NA,"Established Spasticity Resulting from Multiple Sclerosis"
"2007-000486-38-NL","2007-000486-38",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2007-000538-37-DE","2007-000538-37",1,1,"Unknown",1,NA,NA,NA,NA,"Type II diabetes mellitus inadequate control"
"2007-000739-25-BE","2007-000739-25",1,0,"Unknown",0,NA,NA,NA,NA,"metastatic carcinoid tumors whose disease-related symptoms are inadequately controlled by somatostatin analogues"
"2007-000755-33-FR","2007-000755-33",1,0,"Unknown",0,NA,NA,NA,NA,"Patients with T2DM already treated with metformin."
"2007-000860-25-BE","2007-000860-25",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes type 2"
"2007-001557-26-BE","2007-001557-26",1,1,"Diseases C - Cardiovascular Diseases C14",0,8853,391,516,5.8285327007794,"Patients with atrial fibrillation and at least one additional risk factor for stroke who have failed or are unsuitable for vitamin K antagonist therapy."
"2007-001821-85-BE","2007-001821-85",1,0,"Unknown",0,NA,NA,NA,NA,"liver transplantation"
"2007-001972-36-BE","2007-001972-36",1,1,"Unknown",0,736,58,6,0.815217391304348,"Acromegaly is characterized by chronic hypersecretion of growth hormone GH, clinical features comprise structural and functional changes occurring in practically all organs. Cardiovascular disease is the main reason for morbidity and increased mortality."
"2007-002017-39-ES","2007-002017-39",1,1,"Unknown",0,NA,NA,NA,NA,"Hypercholesterolemia or Mixed Dyslipidemia Hipercolesterolemia o dislipidemia mixta"
"2007-002088-29-DK","2007-002088-29",1,1,"Unknown",1,NA,NA,NA,NA,"Balaglitazone is being developed as an oral anti-diabetic drug to improve glycaemic control in patients with type 2 diabetes"
"2007-002218-21-DE","2007-002218-21",1,1,"Unknown",1,NA,NA,NA,NA,"type II diabetes mellitus"
"2007-002223-32-DE","2007-002223-32",1,1,"Unknown",1,NA,NA,NA,NA,"Cardiac surgical patients in whom the use of cardiopulmonary bypass is planned and having at least one ore more of the following risk factors for post-operative acute kidney injury  Age  70 years  Preoperative plasma creatinine 120 mol/L  Heart failure NYHA class III / IV  Insulin dependent diabetes mellitus    Valve surgery with or without coronary artery bypass graft surgery  Redo cardiac surgery"
"2007-002448-10-IT","2007-002448-10",1,1,"Unknown",1,NA,NA,NA,NA,"type 2 diabetic patients with insufficient glycaemic control"
"2007-002450-28-BE","2007-002450-28",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes"
"2007-002456-41-ES","2007-002456-41",1,1,"Unknown",1,NA,NA,NA,NA,"Pacientes con Diabetes Melitus tipo 2 con control glucmico insuficiente. Patients with type 2 Diabetes Mellitus with insufficient glycaemic control."
"2007-002457-24-FI","2007-002457-24",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2007-002492-14-NL","2007-002492-14",1,1,"Unknown",1,NA,NA,NA,NA,"Patients with BMI  or  30 kg/m2 or BMI  27 kg/m2 with associated risk factors such as Type 2 Diabetes mellitus or Dyslipidemia"
"2007-002515-75-BE","2007-002515-75",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes Mellitus"
"2007-002957-22-BE","2007-002957-22",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes"
"2007-003012-61-BE","2007-003012-61",1,1,"Unknown",1,NA,NA,NA,NA,"Non diabetic patients with Non-Alcoholic Steato-Hepatitis"
"2007-003013-14-BE","2007-003013-14",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetic patients with Non-Alcoholic Steato-Hepatitis"
"2007-003131-23-BE","2007-003131-23",1,1,"Unknown",0,NA,NA,NA,NA,"Metabolic Syndrome, Hypertension"
"2007-003371-39-DE","2007-003371-39",1,1,"Unknown",0,NA,NA,NA,NA,"actinic keratosis AK"
"2007-003529-26-DE","2007-003529-26",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes mellitus"
"2007-003548-32-DE","2007-003548-32",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes mellitus"
"2007-003723-21-ES","2007-003723-21",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus Tipo 2"
"2007-003889-18-DE","2007-003889-18",1,1,"Unknown",0,NA,NA,NA,NA,"Treatment of actinic keratosis grade I to II"
"2007-003937-17-ES","2007-003937-17",1,0,"Unknown",1,NA,NA,NA,NA,"type 2 diabetes mellitus  diabetes tipo 2"
"2007-003963-31-SE","2007-003963-31",1,1,"Unknown",1,NA,NA,NA,NA,"Patients with acute myocardial infarction or unstable angina pectoris and newly detected impaired glucose tolerance or type 2 diabetes without any previous pharmacological glucose-lowering treatment"
"2007-003998-55-DE","2007-003998-55",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes"
"2007-004137-42-AT","2007-004137-42",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2007-004448-60-BE","2007-004448-60",1,1,"Unknown",0,NA,NA,NA,NA,"Hypercholesterolemia"
"2007-004585-40-DE","2007-004585-40",1,1,"Unknown",1,NA,NA,NA,NA,"Patients with type 2 diabetes."
"2007-004817-33-ES","2007-004817-33",1,1,"Unknown",0,NA,NA,NA,NA,"The subjects who will participate to this clinical trial are not healthy volonteers. They have Permanent, persistent or paroxysmal non-valvular atrial fibrillation that is ECG-documented, with an indication for long-term VKA therapy.  --------------------------------------- prevencin del ictus y de episodios tromboemblicos sistmicos en pacientes con fibrilacin auricular"
"2007-004833-40-LT","2007-004833-40",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes patients insufficiently controlled with metformin monotherapy"
"2007-004864-29-BE","2007-004864-29",1,0,"Unknown",1,NA,NA,NA,NA,"Type II diabetes mellitus"
"2007-004877-24-BE","2007-004877-24",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetic Macular Edema DME"
"2007-004951-12-LV","2007-004951-12",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2007-005163-94-DE","2007-005163-94",1,0,"Unknown",0,270,1,3,1.11111111111111,"Acute coronary syndrome ACS"
"2007-005220-33-ES","2007-005220-33",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes tipo 2 Type 2 diabetes"
"2007-005317-19-BE","2007-005317-19",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes"
"2007-005434-37-BE","2007-005434-37",1,1,"Unknown",0,1475,81,41,2.77966101694915,"RHEUMATOID ARTHRITIS, NOS"
"2007-005435-28-ES","2007-005435-28",1,1,"Unknown",0,130,9,1,0.769230769230769,"Attention impairment after cancer treatment Trastorno de atencin despus del tratamiento para el cncer"
"2007-005442-20-BE","2007-005442-20",1,1,"Unknown",0,130,5,0,0,"Attention impairment after cancer treatment"
"2007-005495-13-DE","2007-005495-13",0,0,"Unknown",1,NA,NA,NA,NA,"Painful Diabetic Neuropathy Painful Herpetic Neuralgia will not be studied in the EU as the preceding double-blind study was not conducted here"
"2007-005784-10-BE","2007-005784-10",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetic Foot Ulcer"
"2007-005839-28-ES","2007-005839-28",1,1,"Unknown",0,5696,149,46,0.807584269662921,"Hypercholesterolemia, mixed hyperlipidemia Hipercolesterolemia, hiperlipidemia mixta"
"2007-005880-80-ES","2007-005880-80",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes --------------------- Diabetes tipo II"
"2007-005881-11-DE","2007-005881-11",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2007-005883-28-ES","2007-005883-28",1,0,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes --------------------- Diabetes tipo II"
"2007-005884-92-DE","2007-005884-92",1,1,"Unknown",1,NA,NA,NA,NA,"Type II diabetes"
"2007-005886-36-DE","2007-005886-36",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2007-005887-29-BE","2007-005887-29",1,1,"Unknown",1,NA,NA,NA,NA,"Type II diabetes"
"2007-005925-31-IT","2007-005925-31",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes"
"2007-005931-27-PL","2007-005931-27",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2007-006095-11-BE","2007-006095-11",1,1,"Unknown",1,NA,NA,NA,NA,"Non-insulin dependent type 2 diabetes"
"2007-006706-14-DE","2007-006706-14",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus type 2"
"2007-006854-24-DE","2007-006854-24",1,0,"Unknown",0,NA,NA,NA,NA,"Actinic keratosis AK"
"2007-007198-21-ES","2007-007198-21",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus tipo 2"
"2007-007540-10-ES","2007-007540-10",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus tipo 2 Type 2 Diabetes Mellitus"
"2008-000345-55-ES","2008-000345-55",1,0,"Unknown",0,NA,NA,NA,NA,"Cancer de pulmon no microctico"
"2008-000516-32-ES","2008-000516-32",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes tipo 2 tratado con metformina y no suficientemente controlada"
"2008-000521-19-ES","2008-000521-19",NA,NA,"Unknown",1,NA,NA,NA,NA,"Diabetes tipo 2 tratada con metformina pero no suficientemente controlada con unt tratamiento previo de metformina y con insulina glargina o sitagliptina."
"2008-000558-11-BE","2008-000558-11",1,0,"Unknown",0,NA,NA,NA,NA,"H5N1 vaccination in healthy subjects adult and elderly population and in specified risk groups chronically ill, transplant and HIV patients."
"2008-000750-13-BE","2008-000750-13",0,0,"Unknown",1,NA,NA,NA,NA,"Patients with type 2 Diabetes Mellitus."
"2008-000854-11-BE","2008-000854-11",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes"
"2008-000874-19-ES","2008-000874-19",1,1,"Unknown",0,NA,NA,NA,NA,"Hipertensin Hypertension"
"2008-000959-10-DE","2008-000959-10",1,1,"Unknown",1,NA,NA,NA,NA,"Type II diabetes mellitus"
"2008-000976-26-IT","2008-000976-26",1,1,"Unknown",1,NA,NA,NA,NA,"Type II diabetes"
"2008-001002-16-DE","2008-001002-16",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2008-001038-28-BE","2008-001038-28",0,0,"Unknown",0,NA,NA,NA,NA,"Prophylaxis of Influenza"
"2008-001049-24-BE","2008-001049-24",1,1,"Unknown",1,3723,230,6,0.16116035455278,"Obesity and overweight Pre-diabetes"
"2008-001050-40-FR","2008-001050-40",1,0,"Unknown",1,NA,NA,NA,NA,"type 2 diabetes"
"2008-001089-10-FR","2008-001089-10",1,1,"Unknown",1,NA,NA,NA,NA,"DIABETES, NOS"
"2008-001243-18-ES","2008-001243-18",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus Tipo 2"
"2008-001246-21-DE","2008-001246-21",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2008-001454-40-IT","2008-001454-40",0,0,"Unknown",0,NA,NA,NA,NA,"tipe I dyabete"
"2008-001640-40-DE","2008-001640-40",1,1,"Unknown",1,NA,NA,NA,NA,"Patients with type 2 diabetes   with insufficient glycaemic control HbA1c  7.5 to  11  at Visit 2  with very poor glycaemic control HbA1c  11"
"2008-001744-39-DE","2008-001744-39",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2008-001765-28-SK","2008-001765-28",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2008-001854-42-ES","2008-001854-42",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus Diabetes Mellitus tipo II"
"2008-001855-23-BE","2008-001855-23",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2008-001856-36-ES","2008-001856-36",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus tipo 2"
"2008-001921-33-ES","2008-001921-33",1,1,"Unknown",1,NA,NA,NA,NA,"DIABETES"
"2008-002121-36-DE","2008-002121-36",1,1,"Unknown",1,NA,NA,NA,NA,"Treatment of Type 2 Diabetes"
"2008-002199-88-ES","2008-002199-88",1,1,"Unknown",0,NA,NA,NA,NA,"Obesidad y sobrepeso"
"2008-002205-40-DE","2008-002205-40",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,NA,NA,NA,NA,"Otelixizumab is being developed for the treatment of patients with autoimmune T1DM with residual beta cell function RBCF, with the goal of preserving RBCF in this patient population. There are currently no approved treatments for this indication. Approved treatments for T1DM in the EU are insulins or insulin analogues."
"2008-002439-33-IT","2008-002439-33",1,1,"Unknown",0,NA,NA,NA,NA,"Patients with essential hypertension and with at least one additional cardiovascular risk factor, not controlled by a previous monotherapy"
"2008-002708-25-BE","2008-002708-25",1,1,"Unknown",0,NA,NA,NA,NA,"Acute Coronary Syndrome ACS"
"2008-002843-18-BE","2008-002843-18",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetic Sensorimotor Polyneuropathy"
"2008-003118-86-HU","2008-003118-86",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes with insufficient glycaemic control HbA1c 7.0-10 despite background therapy with a sulfonylurea drug"
"2008-003640-11-IT","2008-003640-11",1,1,"Unknown",1,NA,NA,NA,NA,"Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control."
"2008-003843-36-GR","2008-003843-36",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2008-004412-12-SK","2008-004412-12",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2008-004522-16-BE","2008-004522-16",1,1,"Diseases C - Cardiovascular Diseases C14",0,NA,NA,NA,NA,"Reduction of Stroke and/or systemic embolic event SEE in subjects with atrial fibrillation AF."
"2008-004722-16-BE","2008-004722-16",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2008-004881-16-ES","2008-004881-16",1,1,"Unknown",0,NA,NA,NA,NA,"Enfermedad coronaria"
"2008-004913-93-HU","2008-004913-93",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2008-004953-14-DK","2008-004953-14",1,1,"Unknown",0,NA,NA,NA,NA,"hypercholesterolemia"
"2008-005012-41-DE","2008-005012-41",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes"
"2008-005030-73-DE","2008-005030-73",1,1,"Unknown",1,NA,NA,NA,NA,"- Incidence of CV outcomes compared to placebo for the TZD class as a whole, rosiglitazone RSG, and pioglitazone PIO when added to the therapeutic regimen of a person with type 2 diabetes who has additional risk factors for CV events.   - Determine whether adding vitamin D in such individuals is superior to adding placebo with respect to reducing the incidence of death or serious cancers requiring hospitalization, chemotherapy or surgery compared to placebo."
"2008-005248-17-BE","2008-005248-17",NA,NA,"Unknown",1,NA,NA,NA,NA,"This is a study of the long term safety of dabigatran intended indication: stroke prevention in patients with atrial fibrillation.Eligible patients received dabigatran during the RE-LY trial 1160.26.At the time of entry into RE-LY, patients had at least one risk factor for stroke 1 congestive heart failure, 2 left ventricular dysfunction, 3 age 75, 4 age 65 years with hypertension, diabetes or coronary artery disease or 5 previous stroke, systemic embolism or transient ischemic attack"
"2008-005546-23-DE","2008-005546-23",1,1,"Diseases C - Nervous System Diseases C10",0,3876,227,282,7.27554179566563,"Insulin resistance in patients who have had a stroke or transient ischaemic attack"
"2008-005575-96-BE","2008-005575-96",1,1,"Unknown",0,15802,399,1159,7.33451461840273,"chronic Coronary Heart Disease cCHD"
"2008-005767-34-FR","2008-005767-34",1,0,"Unknown",1,NA,NA,NA,NA,"type 2 diabetes mellitus"
"2008-005768-15-SE","2008-005768-15",1,0,"Unknown",1,NA,NA,NA,NA,"type 2 diabetes"
"2008-005769-71-FR","2008-005769-71",1,0,"Unknown",1,NA,NA,NA,NA,"type 1 diabetes"
"2008-005771-10-FI","2008-005771-10",1,0,"Unknown",1,NA,NA,NA,NA,"type 2 diabetes mellitus"
"2008-005774-13-DE","2008-005774-13",1,0,"Unknown",1,NA,NA,NA,NA,"type 1 diabetes"
"2008-005776-27-BE","2008-005776-27",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes"
"2008-005777-35-ES","2008-005777-35",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus type 2 Diabetes mellitus tipo 2"
"2008-005809-20-ES","2008-005809-20",1,1,"Unknown",1,NA,NA,NA,NA,"Pacientes con Diabetes Tipo 2 Patients with Type 2 diabetes"
"2008-005892-83-GB","2008-005892-83",1,1,"Body processes G - Metabolic Phenomena G03",0,400,95,0,0,"Obesity in pregnancy.   Obesity in pregnancy has been identified by Confidential Enquiry into Maternal And Child Health CEMACH 2008-2011 as a major health risk to mother and baby."
"2008-005972-29-BE","2008-005972-29",1,1,"Unknown",0,NA,NA,NA,NA,"The investigation will be carried out on subjects with Acute Coronary Syndromes."
"2008-006176-30-DE","2008-006176-30",1,1,"Unknown",0,NA,NA,NA,NA,"Chronic neuropathic low back pain."
"2008-006177-32-ES","2008-006177-32",1,1,"Unknown",0,NA,NA,NA,NA,"Linfoma de clulas del manto Mantle-Cell Lymphoma"
"2008-006317-25-DE","2008-006317-25",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes"
"2008-006439-12-BE","2008-006439-12",1,0,"Diseases C - Virus Diseases C02",0,4684,NA,151,3.22374039282664,"HIV Infection"
"2008-006447-40-BE","2008-006447-40",1,1,"Unknown",0,NA,NA,NA,NA,"Progression of atherosclerosis in hypertensive patients with coronary artery disease"
"2008-006719-20-BE","2008-006719-20",1,1,"Body processes G - Metabolic Phenomena G03",1,14540,NA,111,0.763411279229711,"Type 2 diabetes mellitus T2DM"
"2008-006720-62-ES","2008-006720-62",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus tipo 2 Type 2 diabetes mellitus"
"2008-007334-22-DE","2008-007334-22",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2008-007335-40-DE","2008-007335-40",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2008-007444-34-ES","2008-007444-34",1,1,"Unknown",1,NA,NA,NA,NA,"Pacientes con diabetes mellitus de tipo II DMT2 actualmente en tratamiento con una dosis diaria estable de metformina sola, pero que tienen un control glucmico insuficiente.  Patients with type II diabetes mellitus T2DM who are currently treated with a stable daily dose of metformin alone but experiencing inadequate glycemic control"
"2008-007660-41-ES","2008-007660-41",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus de tipo 2 Type 2 Diabetes Mellitus"
"2008-007661-24-ES","2008-007661-24",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus de tipo 2 Type 2 Diabetes Mellitus"
"2008-007662-37-ES","2008-007662-37",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus de tipo 2 Type 2 Diabetes Mellitus"
"2008-007664-42-ES","2008-007664-42",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus de tipo 2 Type 2 Diabetes Mellitus"
"2008-007681-30-IT","2008-007681-30",1,1,"Unknown",0,NA,NA,NA,NA,"Essential hypertension"
"2008-007689-52-DE","2008-007689-52",1,1,"Unknown",1,NA,NA,NA,NA,"Lipids not at goal in diabetic patients with cardiovascular disease"
"2008-008127-15-ES","2008-008127-15",1,1,"Unknown",1,NA,NA,NA,NA,"type 2 diabetes mellitus Diabetes Mellitus tipo 2"
"2008-008287-28-DE","2008-008287-28",0,0,"Unknown",1,NA,NA,NA,NA,"Patients with prediabetes either impaired glucose tolerance or imparied fasting glucose and no obvious diabetes mellitus"
"2008-008296-33-BE","2008-008296-33",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes pretreated with basal Insulin therapy"
"2008-008298-77-BE","2008-008298-77",1,1,"Unknown",0,NA,NA,NA,NA,"Subjects with a recent acute coronary syndrome ACS and at least 2 additional risk factors for recurrent ischemic events."
"2008-008494-59-DE","2008-008494-59",1,1,"Unknown",1,NA,NA,NA,NA,"Patients with type 2 diabetes previously completing the double-blind part of study 1218.46"
"2009-009157-24-ES","2009-009157-24",1,1,"Unknown",1,NA,NA,NA,NA,"Pacientes con diabetes mellitus tipo 2 Patients with Type 2 diabetes"
"2009-009320-36-DE","2009-009320-36",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2009-009500-39-BE","2009-009500-39",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes"
"2009-009889-13-BE","2009-009889-13",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes Mellitus"
"2009-010063-16-ES","2009-010063-16",1,1,"Unknown",0,NA,NA,NA,NA,"Neuropata Diabtica Dolorosa"
"2009-010170-38-ES","2009-010170-38",1,1,"Unknown",0,NA,NA,NA,NA,"enfermedad cardiovascular, hipertensin funcional"
"2009-010224-25-DE","2009-010224-25",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2009-010536-17-ES","2009-010536-17",1,1,"Unknown",0,NA,NA,NA,NA,"Edema macular despus de intervencin de cataratas. macular edema following cataract surgery"
"2009-010662-28-FR","2009-010662-28",1,0,"Unknown",1,NA,NA,NA,NA,"type 2 diabetes mellitus"
"2009-010830-23-IE","2009-010830-23",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes"
"2009-010900-27-BE","2009-010900-27",0,0,"Unknown",0,NA,NA,NA,NA,"Prophylaxis of Influenza"
"2009-011150-17-BE","2009-011150-17",1,1,"Diseases C - Cardiovascular Diseases C14",0,605,57,70,11.5702479338843,"Pulmonary arterial hypotension"
"2009-011222-34-BE","2009-011222-34",1,1,"Diseases C - Cardiovascular Diseases C14",1,NA,NA,NA,NA,"Type 2 diabetes mellitus T2DM and acute coronary syndrome ACS"
"2009-011231-12-ES","2009-011231-12",1,0,"Unknown",1,125,9,0,0,"Pacientes con diabetes mellitus tipo 1, entre 1 y 6 aos _______________________________________________ Patients with type 1 diabetes mellitus, aged at least 1 year to less than 6 years"
"2009-011271-78-ES","2009-011271-78",1,0,"Unknown",1,NA,NA,NA,NA,"type 2 diabetes Diabetes tipo 2"
"2009-011398-33-CZ","2009-011398-33",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes"
"2009-011399-31-FR","2009-011399-31",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2009-011606-41-BE","2009-011606-41",1,1,"Body processes G - Metabolic Phenomena G03",1,NA,NA,NA,NA,"Recent-onset type 1 diabetes mellitus"
"2009-011672-29-IT","2009-011672-29",1,0,"Unknown",1,NA,NA,NA,NA,"type 1 diabetes"
"2009-012011-17-BE","2009-012011-17",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes"
"2009-012140-16-BE","2009-012140-16",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,4327,136,208,4.80702565287728,"Type 2 diabetes mellitus and history or high risk cardiovascular disease"
"2009-012201-19-BE","2009-012201-19",1,1,"Unknown",1,9340,368,829,8.87580299785867,"Type 2 diabetes mellitus"
"2009-012269-71-ES","2009-012269-71",1,1,"Unknown",1,7174,422,4,0.0557568999163646,"Pacientes con diabetes tipo 2 con un episodio reciente de sndrome coronario agudo SCA. Type 2 diabetes patients with a recent acute coronary syndrome ACS event."
"2009-012367-34-BE","2009-012367-34",1,1,"Diseases C - Virus Diseases C02",0,NA,NA,NA,NA,"Influenza"
"2009-012581-32-BE","2009-012581-32",1,1,"Diseases C - Cardiovascular Diseases C14",0,12917,371,779,6.03081210807463,"after recent Acute Coronary Syndrome ACS"
"2009-012597-13-LT","2009-012597-13",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus T2DM"
"2009-012652-24-LT","2009-012652-24",1,1,"Body processes G - Metabolic Phenomena G03",1,NA,NA,NA,NA,"Type II diabetes mellitus T2DM"
"2009-012772-27-ES","2009-012772-27",1,1,"Unknown",0,NA,NA,NA,NA,"Dyslipidemia. Dislipidemia"
"2009-012775-10-BE","2009-012775-10",1,1,"Unknown",1,NA,NA,NA,NA,"Non-insulin dependent type 2 diabetes mellitus"
"2009-012806-37-DE","2009-012806-37",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2009-012816-41-ES","2009-012816-41",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus tipo 2 no insulino dependiente en pacientes ancianos / 65 aos Non-insulin dependent type 2 diabetes mellitus in elderly patients / 65 years"
"2009-012852-26-BE","2009-012852-26",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,6063,377,189,3.11726867887185,"Type II Diabetes"
"2009-012923-27-BE","2009-012923-27",1,0,"Unknown",1,NA,NA,NA,NA,"Type 1 diabetes"
"2009-013157-15-BE","2009-013157-15",1,1,"Body processes G - Metabolic Phenomena G03",0,6033,386,644,10.6746229073429,"Patients with documented diagnosis of T2DM with insufficient glycaemic control and at high risk of CV events prior to informed consent can be enrolled in the study."
"2009-013289-20-FR","2009-013289-20",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2009-013412-13-FR","2009-013412-13",1,0,"Unknown",1,NA,NA,NA,NA,"Type 1 diabetes"
"2009-014391-22-ES","2009-014391-22",1,0,"Unknown",0,NA,NA,NA,NA,"Infecciones complicadas de piel y tejidos blandos  Complicated skin and soft tissue infections."
"2009-014803-30-BE","2009-014803-30",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2009-014841-10-ES","2009-014841-10",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus Tipo 2 Type 2 Diabetes Mellitus"
"2009-014986-22-ES","2009-014986-22",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus tipo II.  Patients with Type 2 diabetes"
"2009-015018-23-BE","2009-015018-23",1,1,"Unknown",0,NA,NA,NA,NA,"Treatment and prevention of gout flares in patients with frequent flares, who have pre-defined co-morbidities and for whom NSAIDs and colchicine are contraindicated, not tolerated or ineffective"
"2009-015247-16-BE","2009-015247-16",1,1,"Body processes G - Metabolic Phenomena G03",0,NA,NA,NA,NA,"Primary Hypercholesterolemia"
"2009-015255-25-NL","2009-015255-25",1,1,"Unknown",1,NA,NA,NA,NA,"Patients with type 2 diabetes."
"2009-015386-30-ES","2009-015386-30",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes melitus de tipo 2. Type 2 Diabetes Mellitus"
"2009-015721-36-IT","2009-015721-36",0,0,"Unknown",1,NA,NA,NA,NA,"type 1 diabetes mellitus"
"2009-015754-38-BE","2009-015754-38",0,0,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes"
"2009-015755-24-DE","2009-015755-24",0,0,"Unknown",1,NA,NA,NA,NA,"Type 1 diabetes"
"2009-015816-17-ES","2009-015816-17",0,0,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes Diabetes Tipo 2"
"2009-015839-33-ES","2009-015839-33",0,0,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Diabetes tipo 2"
"2009-015877-11-DE","2009-015877-11",1,0,"Diseases C - Virus Diseases C02",0,516,20,10,1.93798449612403,"Prevention of hepatitis B virus HBV infection"
"2009-015883-32-ES","2009-015883-32",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus Tipo II"
"2009-015929-37-ES","2009-015929-37",1,1,"Unknown",1,474,112,2,0.421940928270042,"Diabetes tipo 1"
"2009-016053-18-NL","2009-016053-18",1,1,"Unknown",1,NA,NA,NA,NA,"The effect of vildagliptin on endothelial dysfunction in type 2 diabetes, assessed by measuring endothelium-dependent vasodilatation"
"2009-016154-40-GR","2009-016154-40",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2009-016178-33-BE","2009-016178-33",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,11707,529,471,4.02323396258649,"The study will be performed in patients with type 2 diabetes mellitus and high cardiovascular risk who have insufficient glycaemic control despite diet and exercise and are either treatment nave or receiving any antidiabetic background therapy. Drug-nave is defined as absence of any antidiabetic therapy for 12 weeks prior to randomisation."
"2009-016179-31-ES","2009-016179-31",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus Tipo 2 Type 2 Diabetes Mellitus"
"2009-016243-20-BE","2009-016243-20",1,1,"Unknown",1,NA,NA,NA,NA,"Patients with type 2 diabetes mellitus."
"2009-016244-39-ES","2009-016244-39",1,1,"Unknown",1,1545,129,16,1.03559870550162,"Diabetes mellitus de tipo 2 en tratamiento con metformina. Type 2 diabetes mellitus pre-treated with metformin"
"2009-016258-41-DE","2009-016258-41",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"The study will be performed in patients age of 18 or more with type 2 diabetes and insufficient glycaemic control despite a background therapy of metformin or metformin plus a sulfonylurea."
"2009-016366-88-BE","2009-016366-88",1,1,"Unknown",1,NA,NA,NA,NA,"type 2 diabetes mellitus T2DM with inadequate glycemic control on combination therapy with metformin and a sulphonylurea SU"
"2009-016458-42-BE","2009-016458-42",1,0,"Health Care N - Population Characteristics N01",1,313,26,2,0.638977635782748,"Painful Diabetic Peripheral Neuropathy"
"2009-016525-34-IT","2009-016525-34",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus With Inadequate Glycemic Control"
"2009-016791-71-ES","2009-016791-71",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus tipo 2 Type 2 diabetes mellitus"
"2009-016971-31-FI","2009-016971-31",1,1,"Unknown",1,NA,NA,NA,NA,"Patients with type 2 diabetes."
"2009-017061-28-DE","2009-017061-28",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"type 2 diabetes mellitus"
"2009-017136-40-BE","2009-017136-40",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus with Moderate Renal Impairment"
"2009-017242-30-BE","2009-017242-30",1,1,"Diseases C - Cardiovascular Diseases C14",0,20942,948,952,4.54588864482857,"Myocardial Infarction, Cardiovascular Death, Atherothombosis, Stroke"
"2009-017311-15-BE","2009-017311-15",1,0,"Unknown",0,NA,NA,NA,NA,"prophylaxis of liver allograft rejection in liver transplant recipients"
"2009-017336-40-DE","2009-017336-40",0,0,"Unknown",0,NA,NA,NA,NA,"Hypertension"
"2009-017358-10-ES","2009-017358-10",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus tipo II Type 2 diabetes mellitus"
"2009-017524-36-HU","2009-017524-36",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus T2DM"
"2009-018070-64-ES","2009-018070-64",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes melitus II con control de la glucemia inadecuado"
"2010-018318-62-HU","2010-018318-62",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus type 2"
"2010-018350-13-BE","2010-018350-13",0,0,"Unknown",0,NA,NA,NA,NA,"Prophylaxis of Influenza"
"2010-018354-12-DE","2010-018354-12",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 1 Diabetes mellitus"
"2010-018369-48-AT","2010-018369-48",1,0,"Unknown",0,NA,NA,NA,NA,"Psoriasis vulgaris"
"2010-018411-15-ES","2010-018411-15",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus tipo 2"
"2010-018774-21-ES","2010-018774-21",1,1,"Unknown",0,260,1,0,0,"Hipertensin"
"2010-018775-17-BE","2010-018775-17",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 1 Diabetes Mellitus"
"2010-018979-16-DE","2010-018979-16",1,1,"Unknown",1,NA,NA,NA,NA,"diabetes mellitus"
"2010-019100-23-DE","2010-019100-23",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetic Neuropathic Pain"
"2010-019223-55-BE","2010-019223-55",1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2010-019428-30-GB","2010-019428-30",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2010-019511-37-DE","2010-019511-37",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitis"
"2010-019690-15-ES","2010-019690-15",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus de tipo 2. Type 2 Diabetes Mellitus."
"2010-019777-15-ES","2010-019777-15",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus de tipo 2 e insuficiencia renal. Type 2 Diabetes Mellitus With Renal Impairment."
"2010-019791-73-BE","2010-019791-73",1,1,"Unknown",0,NA,NA,NA,NA,"Atrial Fibrillation"
"2010-019795-74-BE","2010-019795-74",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetic Macular Edema DME"
"2010-019797-32-ES","2010-019797-32",1,1,"Unknown",1,NA,NA,NA,NA,"varones y mujeres con diabetes de tipo 2, edad 18 y  89 aos e hipertensin arterial controlada de manera insuficiente."
"2010-019798-13-DE","2010-019798-13",1,1,"Diseases C - Cardiovascular Diseases C14",1,NA,NA,NA,NA,"Type 2 diabetes with inadequate glycemic control and inadequately controlled hypertension"
"2010-019968-37-BE","2010-019968-37",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2010-020015-36-DE","2010-020015-36",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Diabetes mellitus Type II"
"2010-020053-14-BE","2010-020053-14",1,1,"Unknown",1,755,43,2,0.264900662251656,"Type 2 Diabetes Mellitus"
"2010-020234-26-PL","2010-020234-26",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2010-020360-38-BE","2010-020360-38",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,8,3,0,0,"diabetes type 2"
"2010-020684-20-BE","2010-020684-20",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes Mellitus"
"2010-020946-80-ES","2010-020946-80",NA,NA,"Unknown",1,NA,NA,NA,NA,"Sujetos con diabetes de tipo I o II con edema macular diabtico EMD y retinopata diabtica, proliferativa o no."
"2010-021069-63-BE","2010-021069-63",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,14716,NA,1091,7.41369937483012,"Type 2 diabetes mellitus"
"2010-021097-11-DE","2010-021097-11",1,1,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes Mellitus"
"2010-021236-34-DE","2010-021236-34",1,0,"Unknown",1,NA,NA,NA,NA,"Type II Diabetes"
"2010-021373-37-BE","2010-021373-37",1,0,"Unknown",1,472,33,11,2.33050847457627,"Type 1 diabetes"
"2010-021375-92-ES","2010-021375-92",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1413,74,0,0,"Type 2 diabetes mellitus"
"2010-021424-94-ES","2010-021424-94",1,1,"Diseases C - Bacterial Infections and Mycoses C01",0,NA,NA,NA,NA,"Treatment of Patients with acute bacterial skin and skin structure infections"
"2010-021560-15-ES","2010-021560-15",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 2 diabetes"
"2010-021638-72-BE","2010-021638-72",1,1,"Diseases C - Respiratory Tract Diseases C08",0,16568,683,0,0,"Subjects with moderate Chronic Obstructive Pulmonary Disease COPD"
"2010-021720-10-ES","2010-021720-10",1,1,"Diseases C - Bacterial Infections and Mycoses C01",0,NA,NA,NA,NA,"Treatment of Patients with acute bacterial skin and skin structure infections"
"2010-022337-29-ES","2010-022337-29",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus tipo 2. Type 2 diabetes mellitus."
"2010-022364-12-ES","2010-022364-12",1,1,"Unknown",1,404,17,17,4.20792079207921,"Edema macular diabtico con afectacin central// Diabetic macular edema with central involvement"
"2010-022372-31-DE","2010-022372-31",0,0,"Diseases C - Virus Diseases C02",0,56,1,3,5.35714285714286,"Prevention of Hepatitis B virus HBV infection"
"2010-022433-29-DK","2010-022433-29",1,1,"Unknown",1,NA,NA,NA,NA,"Diabetic retinopathy"
"2010-022616-39-GB","2010-022616-39",0,0,"Diseases C - Eye Diseases C11",1,NA,NA,NA,NA,"Diabetic Macular Oedema"
"2010-022658-18-BE","2010-022658-18",1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2010-022677-34-DE","2010-022677-34",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 1 diabetes mellitus or Addisons disease ViDDA1"
"2010-022718-17-BE","2010-022718-17",0,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 2 Diabetes mellitus"
"2010-022970-14-BE","2010-022970-14",1,1,"Diseases C - Cardiovascular Diseases C14",0,15843,778,1296,8.18026888846809,"atherosclerosis"
"2010-023198-21-GB","2010-023198-21",1,0,"Unknown",1,267,71,0,0,"Type-1 Diabetes"
"2010-023467-18-DE","2010-023467-18",1,1,"Diseases C - Cardiovascular Diseases C14",0,30449,12,2277,7.47807809780288,"atherosclerotic cardiovascular disease"
"2010-023759-27-ES","2010-023759-27",1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus tipo 2 Type 2 diabetes mellitus"
"2010-023769-23-DE","2010-023769-23",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,806,43,4,0.496277915632754,"Type 2 Diabetes Mellitus"
"2010-023770-39-ES","2010-023770-39",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,809,48,4,0.494437577255871,"Type 2 Diabetes Mellitus"
"2010-023792-25-GB","2010-023792-25",1,0,"Unknown",1,293,1,0,0,"Type 1 Diabetes Mellitus"
"2010-023799-21-ES","2010-023799-21",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,9892,760,519,5.24666397088556,"Cardiovascular events in patients with Type 2 diabetes"
"2010-024049-53-BE","2010-024049-53",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,1143,63,2,0.174978127734033,"Diabetes Mellitus, Type 1"
"2010-024051-93-SK","2010-024051-93",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,682,38,2,0.293255131964809,"Diabetes Mellitus, Type 2"
"2010-024054-11-BE","2010-024054-11",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,472,18,0,0,"Diabetes Mellitus, Type 1"
"2010-024568-16-BE","2010-024568-16",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,6,2,0,0,"diabetes type 2"
"2011-000220-16-ES","2011-000220-16",1,1,"Diseases C - Cardiovascular Diseases C14",0,NA,NA,NA,NA,"Essential Hypertension Hipertensin Esencial"
"2011-000300-18-NL","2011-000300-18",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,428,104,7,1.63551401869159,"Type 1 diabetes mellitus"
"2011-000347-25-DE","2011-000347-25",1,1,"Body processes G - Metabolic Phenomena G03",1,NA,NA,NA,NA,"Patients with type-2-diabetes mellitus"
"2011-000383-10-ES","2011-000383-10",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1363,80,7,0.513573000733676,"Type 2 Diabetes Mellitus"
"2011-000400-17-HU","2011-000400-17",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1186,30,1,0.0843170320404722,"Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise"
"2011-000828-15-ES","2011-000828-15",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 2 to Diabetes Mellitus"
"2011-000829-73-BE","2011-000829-73",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"type 1 diabetes"
"2011-000842-39-ES","2011-000842-39",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1538,9,0,0,"Type 2 Diabetes Mellitus"
"2011-000997-77-PL","2011-000997-77",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,431,18,1,0.232018561484919,"Type 2 Diabetes Mellitus"
"2011-001253-82-BE","2011-001253-82",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1112,4,0,0,"Type 1 Diabetes Mellitus"
"2011-001254-29-ES","2011-001254-29",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1368,5,0,0,"Type 2 Diabetes Mellitus"
"2011-001261-40-DE","2011-001261-40",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,453,1,0,0,"Type 1 Diabetes Mellitus"
"2011-001283-22-DE","2011-001283-22",0,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type II diabetes  The medical condition investigated in the REGULATE trial CL3-00780-148 was type II diabetes. The applied CL3-00780-150 trial, REGULATE follow-up study, is thus performed in diabetic patients."
"2011-001483-21-ES","2011-001483-21",1,1,"Body processes G - Metabolic Phenomena G03",0,NA,NA,NA,NA,"Hipercolesterolemia Heterocigotica Familiar Heterozygous Familial Hypercholesterolaemia"
"2011-001493-25-BE","2011-001493-25",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 2 diabetes"
"2011-001539-21-DE","2011-001539-21",1,0,"Body processes G - Immune system processes G12",0,130,9,0,0,"lung transplantation"
"2011-001635-23-BE","2011-001635-23",1,0,"Diseases C - Virus Diseases C02",0,273,1,1,0.366300366300366,"HIV-1 infection"
"2011-001712-61-DE","2011-001712-61",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2011-001731-24-LV","2011-001731-24",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,2451,99,11,0.448796409628723,"Type 2 diabetes mellitus T2DM"
"2011-001732-37-DE","2011-001732-37",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,3204,59,25,0.780274656679151,"Type 2 diabetes mellitus T2DM"
"2011-001935-21-IT","2011-001935-21",NA,NA,"Diseases C - Hormonal diseases C19",1,NA,NA,NA,NA,"Diabetes"
"2011-002231-26-ES","2011-002231-26",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,218,NA,0,0,"Type II diabetes mellitus"
"2011-002273-29-DE","2011-002273-29",1,1,"Diseases C - Cardiovascular Diseases C14",0,NA,NA,NA,NA,"Angina"
"2011-002336-72-DK","2011-002336-72",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 2 diabetes"
"2011-002416-85-ES","2011-002416-85",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type II Diabetes Mellitus"
"2011-002451-33-PL","2011-002451-33",1,1,"Diseases C - Respiratory Tract Diseases C08",0,NA,NA,NA,NA,"Chronic Obstructive Pulmonary Disease COPD"
"2011-002528-42-ES","2011-002528-42",1,1,"Diseases C - Hormonal diseases C19",1,199,1,1,0.50251256281407,"Type 2 Diabetes Mellitus"
"2011-002529-23-DE","2011-002529-23",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,440,28,2,0.454545454545455,"Type 2 Diabetes Mellitus"
"2011-002605-29-BE","2011-002605-29",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,234,17,0,0,"Diabetes Mellitus, Type 2"
"2011-002696-41-DE","2011-002696-41",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,450,24,0,0,"Diabetes Mellitus, Type 2"
"2011-002731-26-IT","2011-002731-26",NA,NA,"Diseases C - Eye Diseases C11",1,612,1,3,0.490196078431373,"Diabetic macular edema"
"2011-002741-35-SK","2011-002741-35",1,1,"Diseases C - Hormonal diseases C19",1,421,22,1,0.237529691211401,"Type 2 diabetes mellitus T2DM"
"2011-002743-10-IT","2011-002743-10",1,1,"Diseases C - Nervous System Diseases C10",1,548,20,0,0,"painful diabetic peripheral neuropathy"
"2011-002866-19-IT","2011-002866-19",1,0,"Diseases C - Immune System Diseases C20",0,383,125,5,1.30548302872063,"Renal transplantation"
"2011-002931-25-PL","2011-002931-25",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,464,41,1,0.21551724137931,"Type 2 Diabetes Mellitus"
"2011-002968-24-PL","2011-002968-24",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,277,10,5,1.80505415162455,"Diabetes Mellitus, Type 2"
"2011-003148-39-DE","2011-003148-39",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,349,20,0,0,"Diabetes Mellitus, Type 1"
"2011-003266-32-SE","2011-003266-32",1,1,"Diseases C - Nervous System Diseases C10",1,NA,NA,NA,NA,"Painful Diabetic Peripheral Neuropathy"
"2011-003339-74-GB","2011-003339-74",1,0,"Diseases C - Eye Diseases C11",1,80,1,0,0,"Diabetic macular oedema"
"2011-003603-37-DE","2011-003603-37",1,0,"Diseases C - Virus Diseases C02",0,539,62,2,0.371057513914657,"Pandemic Influenza"
"2011-003810-18-ES","2011-003810-18",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,599,28,0,0,"Diabetes Mellitus, Type 2"
"2011-003815-46-NL","2011-003815-46",1,1,"Diseases C - Cancer C04",0,96,1,0,0,"Acute lymphoblastic leukemia"
"2011-003827-37-BE","2011-003827-37",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,901,64,2,0.221975582685905,"Hyperlipidemia"
"2011-003971-12-ES","2011-003971-12",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,499,42,0,0,"Type 1 Diabetes Mellitus"
"2011-004013-16-BE","2011-004013-16",1,1,"Diseases C - Bacterial Infections and Mycoses C01",0,761,19,5,0.657030223390276,"complicated bacterial skin and soft tissue infections"
"2011-004327-13-BE","2011-004327-13",0,0,"Psychiatry and Psychology F - Mental Disorders F03",0,NA,NA,NA,NA,"Schizophrenia"
"2011-004622-96-BE","2011-004622-96",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2011-004665-32-DE","2011-004665-32",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,343,25,0,0,"Diabetes Mellitus, Type 2"
"2011-004726-10-NL","2011-004726-10",1,1,"Diseases C - Cardiovascular Diseases C14",0,8179,402,584,7.14023719281086,"Cardiovascular Disease or at High Risk for Cardiovascular Disease"
"2011-004930-33-PT","2011-004930-33",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,575,19,0,0,"Diabetes Mellitus, Type 2"
"2011-004964-32-ES","2011-004964-32",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,106,18,0,0,"high-risk hyperlipidaemia"
"2011-004983-32-ES","2011-004983-32",0,0,"Diseases C - Nutritional and Metabolic Diseases C18",0,112,84,0,0,"hyperlipidaemia"
"2011-005224-18-DE","2011-005224-18",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"patients with diabetes mellitus type 2 and iron deficiency"
"2011-005400-15-BE","2011-005400-15",0,0,"Diseases C - Congenital, Hereditary, and Neonatal Diseases and Abnormalities C16",0,600,28,14,2.33333333333333,"Familial Hypercholesterolemia"
"2011-005631-20-BE","2011-005631-20",1,0,"Diseases C - Eye Diseases C11",1,363,16,4,1.10192837465565,"Diabetic Macular Edema"
"2011-005866-39-ES","2011-005866-39",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,464,4,0,0,"Type 2 Diabetes Mellitus"
"2011-005924-16-PL","2011-005924-16",1,1,"Diseases C - Cardiovascular Diseases C14",0,568,10,2,0.352112676056338,"Dyslipidemia"
"2011-006118-15-DE","2011-006118-15",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,151,6,2,1.32450331125828,"type-2 diabetes mellitus with pre-existing cardiovascular disease"
"2011-006161-18-EE","2011-006161-18",1,0,"Diseases C - Virus Diseases C02",0,1736,141,0,0,"Healthy volunteers Active immunization against measles, mumps and rubella diseases in healthy children, 12 to 15 months of age"
"2011-006323-37-PL","2011-006323-37",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,315,14,1,0.317460317460317,"Type 2 Diabetes"
"2011-006324-20-PL","2011-006324-20",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,320,7,1,0.3125,"Type 2 Diabetes"
"2012-000061-21-BE","2012-000061-21",1,1,"Diseases C - Cardiovascular Diseases C14",0,12088,745,527,4.35969556585043,"High Risk Vascular Disease HRVD"
"2012-000140-97-DE","2012-000140-97",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,434,23,1,0.230414746543779,"Diabetes mellitus, Type 2"
"2012-000146-35-NL","2012-000146-35",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,873,88,1,0.11454753722795,"Type 2 diabetes mellitus"
"2012-000209-63-SK","2012-000209-63",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,436,36,0,0,"Diabetes Mellitus, Type 2"
"2012-000373-23-DE","2012-000373-23",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,269,14,2,0.743494423791822,"Diabetes Mellitus, Type 2"
"2012-000451-13-DK","2012-000451-13",1,0,"Body processes G - Immune system processes G12",0,222,NA,4,1.8018018018018,"kidney transplantation"
"2012-000452-34-BE","2012-000452-34",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,209,7,2,0.956937799043062,"Patients with type 2 diabetes mellitus and normoalbuminuria"
"2012-000679-18-IT","2012-000679-18",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,534,NA,0,0,"Type 2 Diabetes in subjects who have Inadequate Glycemic Control on Metformin  Alone"
"2012-000829-44-ES","2012-000829-44",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,576,18,18,3.125,"Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease"
"2012-000975-18-DE","2012-000975-18",1,0,"Diseases C - Digestive System Diseases C06",0,106,6,0,0,"Nonalcoholic Steatohepatitis"
"2012-001006-24-DE","2012-001006-24",0,0,"Diseases C - Eye Diseases C11",1,NA,NA,NA,NA,"therapy of  diabetic macular edema"
"2012-001200-38-DE","2012-001200-38",1,0,"Diseases C - Eye Diseases C11",1,449,32,3,0.66815144766147,"Prevention of neurodegeneration which occurs in Diabetic Retinopathy"
"2012-001259-37-PL","2012-001259-37",1,1,"Body processes G - Metabolic Phenomena G03",1,442,32,0,0,"Type 2 Diabetes Mellitus."
"2012-001314-42-DE","2012-001314-42",1,0,"Body processes G - Immune system processes G12",0,443,25,9,2.03160270880361,"Maintenance of renal transplant recipients"
"2012-001398-97-BE","2012-001398-97",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,27525,2088,0,0,"Dyslipidemia"
"2012-001524-35-NL","2012-001524-35",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,549,30,1,0.182149362477231,"Type 1 diabetes mellitus"
"2012-001868-29-IT","2012-001868-29",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,295,NA,0,0,"Type 2 diabetes mellitus"
"2012-001876-13-EE","2012-001876-13",1,0,"Diseases C - Bacterial Infections and Mycoses C01",0,1300,124,1,0.0769230769230769,"Meningococcal disease"
"2012-001918-42-GB","2012-001918-42",1,1,"Diseases C - Female diseases of the urinary and reproductive systems and pregancy complications C13",0,5201,28,52,0.99980772928283,"pre-eclampsia"
"2012-001930-32-PL","2012-001930-32",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,914,129,3,0.328227571115974,"Diabetes Mellitus, Type 1"
"2012-002117-19-DE","2012-002117-19",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,530,49,0,0,"Type 2 diabetes"
"2012-002232-85-ES","2012-002232-85",0,0,"Diseases C - Virus Diseases C02",0,2435,NA,47,1.93018480492813,"Hepatitis C Virus Infection HCV"
"2012-002270-31-ES","2012-002270-31",1,1,"Body processes G - Metabolic Phenomena G03",1,938,42,0,0,"Type II diabetes mellitus"
"2012-002271-34-ES","2012-002271-34",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1184,43,1,0.0844594594594595,"Diabetes mellitus type 2 is the medical condition to be investiagted"
"2012-002278-30-DE","2012-002278-30",1,1,"Diseases C - Cardiovascular Diseases C14",1,66,69,0,0,"Diabetes mellitus"
"2012-002309-23-DE","2012-002309-23",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,750,131,2,0.266666666666667,"Type 2 Diabetes Mellitus"
"2012-002332-85-ES","2012-002332-85",1,1,"Diseases C - Hormonal diseases C19",1,424,28,8,1.88679245283019,"Type 2 Diabetes Mellitus"
"2012-002333-11-ES","2012-002333-11",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,305,7,1,0.327868852459016,"Patients with Non-familial hypercholesterolemia or heterozygous familial hypercholesterolemia heFH at high CV risk who are not adequately controlled with rosuvastatin 10mg or 20mg with or without other lipid-modifying therapy LMT excluding EZE"
"2012-002344-24-ES","2012-002344-24",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,354,13,2,0.564971751412429,"Patients with Non-familial hypercholesterolemia  or heterozygous familial hypercholesterolemia heFH at high CV risk who are not adequately controlled with atorvastatin 20mg or 40mg with or without other lipid-modifying therapy LMT excluding EZE"
"2012-002346-20-AT","2012-002346-20",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,271,12,1,0.3690036900369,"Diabetes Mellitus, Type 2"
"2012-002414-39-BE","2012-002414-39",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,4192,268,115,2.74332061068702,"Type 2 Diabetes Mellitus"
"2012-002603-17-ES","2012-002603-17",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,360,23,3,0.833333333333333,"Type 2 diabetes patients receiving current standard therapy for diabetic nephropathy ACEi or ARB with micro- or macroalbuminuria UACR between 30 and 3000 mg/g creatinine. ACEiAngiotensin Converting Enzyme inhibitor ARBAngiotensin Receptor Blocker UACR Urinary Albumin Creatinine Ratio"
"2012-002612-10-PL","2012-002612-10",1,1,"Diseases C - Hormonal diseases C19",1,306,13,0,0,"Type 2 Diabetes Mellitus"
"2012-002737-11-DE","2012-002737-11",1,0,"Diseases C - Bacterial Infections and Mycoses C01",0,691,24,0,0,"Meningococcal disease"
"2012-002839-28-ES","2012-002839-28",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,3297,144,122,3.70033363663937,"Diabetes Mellitus, Type 2"
"2012-002911-24-AT","2012-002911-24",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,299,20,0,0,"Diabetes Mellitus, Type 2"
"2012-003011-58-DE","2012-003011-58",1,1,"Diseases C - Cardiovascular Diseases C14",0,NA,NA,NA,NA,"atherosclerosis"
"2012-003110-14-ES","2012-003110-14",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,459,NA,2,0.435729847494553,"Hypercholesterolemia or Low HDL-C"
"2012-003152-37-DE","2012-003152-37",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,40,3,0,0,"Diabetes Mellitus, Type 2"
"2012-003292-19-ES","2012-003292-19",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,350,32,1,0.285714285714286,"Type 2 Diabetes mellitus"
"2012-003566-41-BE","2012-003566-41",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,360,17,0,0,"Diabetes Mellitus, Type 1"
"2012-003580-21-BE","2012-003580-21",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1393,73,3,0.215362526920316,"Diabetes Mellitus, Type 1"
"2012-003626-24-DE","2012-003626-24",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,329,29,1,0.303951367781155,"Type 2 Diabetes Mellitus"
"2012-003661-17-GB","2012-003661-17",1,0,"Diseases C - Eye Diseases C11",1,100,100,2,2,"Diabetic macular oedema"
"2012-003670-11-ES","2012-003670-11",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,804,24,0,0,"Type 2 Diabetes Mellitus"
"2012-003941-13-ES","2012-003941-13",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,639,3,0,0,"Type 2 Diabetes Mellitus"
"2012-004035-23-IT","2012-004035-23",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,440,28,2,0.454545454545455,"Type 2 Diabetes Mellitus"
"2012-004096-38-ES","2012-004096-38",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,893,34,3,0.335946248600224,"Type 2 Diabetes mellitus"
"2012-004180-43-BE","2012-004180-43",1,1,"Diseases C - Cardiovascular Diseases C14",0,27352,38,1941,7.09637320854051,"Prevention of major cardiovascular events in patients with coronary or peripheral artery disease"
"2012-004208-37-BE","2012-004208-37",1,1,"Diseases C - Cardiovascular Diseases C14",0,968,53,5,0.516528925619835,"Coronary Artery Disease"
"2012-004229-25-ES","2012-004229-25",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,300,10,0,0,"Diabetes Mellitus, Type 2"
"2012-004303-12-RO","2012-004303-12",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,203,8,0,0,"Type 2 Diabetes Mellitus"
"2012-004413-14-ES","2012-004413-14",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,557,27,1,0.179533213644524,"Diabetes Mellitus, Type 2"
"2012-004531-23-DE","2012-004531-23",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,568,27,1,0.176056338028169,"Type 2 Diabetes."
"2012-004625-25-AT","2012-004625-25",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,419,22,1,0.238663484486873,"Diabetes Mellitus, Type 2"
"2012-004826-92-DE","2012-004826-92",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,809,53,2,0.247218788627936,"Diabetes Mellitus, Type 2"
"2012-004827-19-ES","2012-004827-19",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1225,49,6,0.489795918367347,"Diabetes Mellitus, Type 2"
"2012-004893-25-GB","2012-004893-25",1,0,"Diseases C - Immune System Diseases C20",0,25,1,0,0,"Lupus nephritis"
"2012-005174-56-DE","2012-005174-56",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,131,4,0,0,"Type 2 Diabetes  Mellitus"
"2012-005183-94-FR","2012-005183-94",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",0,42,1,0,0,"Diabte de type II"
"2012-005482-12-IE","2012-005482-12",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,20,2,1,5,"Diabetic Kidney Disease"
"2012-005505-51-IE","2012-005505-51",1,1,"Diseases C - Skin and Connective Tissue Diseases C17",0,20,10,0,0,"Psoriasis"
"2012-005583-10-SI","2012-005583-10",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,235,8,0,0,"Diabetes Mellitus, Type 2"
"2012-005778-74-BE","2012-005778-74",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,832,30,0,0,"Diabetes Mellitus, Type 1"
"2012-005848-21-BE","2012-005848-21",1,1,"Diseases C - Hormonal diseases C19",1,8766,523,188,2.14464978325348,"Diabetic Nephropathy"
"2013-000059-42-PL","2013-000059-42",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,642,NA,1,0.155763239875389,"Type 2 Diabetes Mellitus"
"2013-000239-28-BE","2013-000239-28",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,17143,194,1098,6.40494662544479,"Type II Diabetes mellitus"
"2013-000301-23-BE","2013-000301-23",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,65,NA,0,0,"Type 2 Diabetes Mellitus"
"2013-000324-34-PL","2013-000324-34",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,11987,584,421,3.51213814966213,"Obese and overweight patients with cardiovascular CV disease and/or multiple CV risk factors"
"2013-000516-25-BE","2013-000516-25",0,0,"Diseases C - Virus Diseases C02",0,248,2,3,1.20967741935484,"Human Immunodeficiency Virus HIV-1 Infection"
"2013-000632-94-IT","2013-000632-94",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,387,14,0,0,"Diabetes Mellitus, Type 2"
"2013-000723-14-FR","2013-000723-14",1,1,"Diseases C - Cardiovascular Diseases C14",1,981,32,0,0,"Hyperlipidemia or mixed dyslipidemia in Diabetic Subjects"
"2013-000768-27-BE","2013-000768-27",1,1,"Diseases C - Nervous System Diseases C10",0,7121,4,131,1.83962926555259,"Embolic stroke of undetermined source ESUS"
"2013-000789-13-BE","2013-000789-13",1,1,"Diseases C - Female diseases of the urinary and reproductive systems and pregancy complications C13",1,154,12,0,0,"Gestational diabetes"
"2013-000830-37-ES","2013-000830-37",1,1,"Diseases C - Hormonal diseases C19",0,557,37,1,0.179533213644524,"Adult or childhood onset growth hormone deficiency GHD"
"2013-001003-36-IT","2013-001003-36",0,0,"Body processes G - Physiological processes G07",1,59,1,1,1.69491525423729,"diabetes type 2"
"2013-001384-23-BE","2013-001384-23",1,0,"Diseases C - Cardiovascular Diseases C14",0,3206,NA,20,0.623830318153462,"Coronary Artery Disease CAD in patients undergoing Percutaneous Coronary Intervention PCI"
"2013-001549-15-FI","2013-001549-15",0,0,"Diseases C - Bacterial Infections and Mycoses C01",0,424,1,0,0,"Meningococcal disease"
"2013-001874-12-ES","2013-001874-12",1,1,"Diseases C - Eye Diseases C11",1,1176,NA,1,0.0850340136054422,"Cataract surgery in diabetic patients"
"2013-002133-37-BE","2013-002133-37",0,0,"Body processes G - Metabolic Phenomena G03",0,94,391,1,1.06382978723404,"Endogenous Cushings syndrome CS or Cushings disease"
"2013-002233-37-DE","2013-002233-37",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,37,2,0,0,"Diabetes Mellitus, Type 1"
"2013-002348-99-GR","2013-002348-99",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,62,2,0,0,"Hypertention, Type 2 Diabetes"
"2013-002371-17-ES","2013-002371-17",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,7637,NA,423,5.53882414560691,"Diabetes Mellitus, Type 2"
"2013-002510-12-DE","2013-002510-12",1,1,"Diseases C - Skin and Connective Tissue Diseases C17",0,87,69,0,0,"Actinic keratosis AK"
"2013-002518-11-ES","2013-002518-11",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,9790,425,721,7.36465781409602,"Type 2 Diabetes Mellitus"
"2013-002519-90-IT","2013-002519-90",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,461,17,1,0.216919739696312,"Type 2 Diabetes Mellitus"
"2013-002642-37-DE","2013-002642-37",1,1,"Diseases C - Cardiovascular Diseases C14",0,709,9,5,0.705218617771509,"primary hyperlipidemia or mixed dyslipidemia"
"2013-002643-28-ES","2013-002643-28",1,1,"Diseases C - Cardiovascular Diseases C14",0,2233,120,11,0.492610837438424,"primary hyperlipidemia or mixed dyslipidemia"
"2013-002644-87-ES","2013-002644-87",1,1,"Diseases C - Cardiovascular Diseases C14",0,370,39,1,0.27027027027027,"Heterozygous Familial Hypercholesterolemia"
"2013-002646-36-BE","2013-002646-36",1,1,"Diseases C - Cardiovascular Diseases C14",0,16760,302,137,0.817422434367542,"atherosclerosis"
"2013-002795-41-BE","2013-002795-41",1,1,"Diseases C - Cardiovascular Diseases C14",0,10555,685,115,1.08953102794884,"atherosclerosis"
"2013-002878-47-ES","2013-002878-47",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,31,1,0,0,"Diabetes Mellitus, Type 2"
"2013-002945-12-ES","2013-002945-12",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,506,61,1,0.197628458498024,"Type1-Diabetes"
"2013-003050-25-BE","2013-003050-25",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,5807,119,139,2.3936628207336,"Patients with type 2 diabetes mellitus T2DM receiving standard of care but with inadequate glycemic control and at elevated risk of cardiovascular CV events"
"2013-003131-30-BE","2013-003131-30",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,1169,83,4,0.342172797262618,"Type II Diabetes Mellitus"
"2013-003132-79-ES","2013-003132-79",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,730,40,3,0.410958904109589,"Type II Diabetes Mellitus"
"2013-003177-99-ES","2013-003177-99",1,0,"Diseases C - Immune System Diseases C20",0,4362,190,153,3.50756533700138,"Rheumatoid Arthritis"
"2013-003241-42-DE","2013-003241-42",1,0,"Diseases C - Skin and Connective Tissue Diseases C17",0,281,277,1,0.355871886120996,"Basal cell carcinoma BCC"
"2013-003272-12-GB","2013-003272-12",1,0,"Body processes G - Ocular Physiological Phenomena G14",1,232,14,3,1.29310344827586,"Proliferative Diabetic Retinopathy PDR"
"2013-003290-95-PL","2013-003290-95",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,621,33,6,0.966183574879227,"Type 2 Diabetes Mellitus"
"2013-003444-24-BE","2013-003444-24",1,1,"Diseases C - Cardiovascular Diseases C14",0,5350,343,114,2.13084112149533,"A study to compare dabigatran etexilate to acetylsalicylic acid in preventing recurrent stroke for patients that already had a stroke caused by an embolus clot.  Despite testing, it is unknown where in the body the embolus developed."
"2013-003449-40-HU","2013-003449-40",0,0,"Body processes G - Immune system processes G12",0,120,115,0,0,"Immunization of healthy children and adolescents against influenza virus infection"
"2013-003519-23-BE","2013-003519-23",1,1,"Diseases C - Cardiovascular Diseases C14",1,19093,2561,410,2.14738385795841,"major cardiovascular events in type 2 diabetes mellitus patients"
"2013-003582-34-CZ","2013-003582-34",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1315,47,10,0.760456273764259,"Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metaformin"
"2013-003587-31-HU","2013-003587-31",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,467,23,11,2.35546038543897,"Type 2 Diabetes Mellitus with Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Background Antihyperglycemic Therapy"
"2013-003640-23-PT","2013-003640-23",1,0,"Diseases C - Eye Diseases C11",1,87,1,0,0,"Patients with type I or type II diabetes mellitus and high risk diabetic retinopathy."
"2013-003697-26-CZ","2013-003697-26",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,462,19,1,0.216450216450216,"Treatment of type 2 diabetes mellitus T2DM and inadequate glycemic control on treatment with metformin and sitagliptin."
"2013-003698-82-IT","2013-003698-82",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1232,49,2,0.162337662337662,"Treatment of type 2 diabetes mellitus T2DM and inadequate glycemic control on treatment with metformin."
"2013-004169-14-DE","2013-004169-14",1,1,"Diseases C - Cardiovascular Diseases C14",1,62,65,0,0,"Type 2 diabetes mellitus"
"2013-004325-91-IT","2013-004325-91",1,0,"Diseases C - Immune System Diseases C20",0,178,13,2,1.12359550561798,"liver transplant"
"2013-004392-12-DE","2013-004392-12",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,1082,36,6,0.55452865064695,"Diabetes Mellitus, Type 2"
"2013-004494-28-ES","2013-004494-28",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,4397,213,357,8.1191721628383,"Type 2 Diabetes Mellitus and Diabetic Kidney Disease"
"2013-004497-10-BE","2013-004497-10",1,1,"Diseases C - Digestive System Diseases C06",0,220,19,0,0,"Active Crohns Disease"
"2013-004502-26-DE","2013-004502-26",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,396,13,0,0,"Diabetes Mellitus, Type 2"
"2013-004674-97-BE","2013-004674-97",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,833,41,1,0.120048019207683,"Type 1 Diabetes Mellitus"
"2013-005334-37-AT","2013-005334-37",0,0,"Diseases C - Nutritional and Metabolic Diseases C18",0,15,4,0,0,"10 patients both gender under treatment with premixed insulin 2-3 injections and HbA1c7 will be switched to basal insulin glargine Lantus, once daily and GLP-1 receptor agonist Lixisenatide Lyxumia, once daily."
"2013-005500-33-ES","2013-005500-33",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,42,2,0,0,"Diabetes Mellitus, Type 2"
"2014-000162-22-BE","2014-000162-22",0,0,"Diseases C - Hormonal diseases C19",0,100,35,0,0,"Treatment of Cushings syndrome"
"2014-000478-20-NL","2014-000478-20",1,1,"Diseases C - Cardiovascular Diseases C14",0,879,69,4,0.455062571103527,"Primary Hyperlipidemia or mixed Dyslipidemia"
"2014-000674-18-IT","2014-000674-18",1,1,"Diseases C - Cardiovascular Diseases C14",0,615,3,0,0,"primary or secondary hypertension"
"2014-000747-32-DE","2014-000747-32",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,558,317,3,0.53763440860215,"Type 1 Diabetes Mellitus"
"2014-000881-23-SK","2014-000881-23",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,558,141,0,0,"Type 2 Diabetes mellitus"
"2014-000936-40-DE","2014-000936-40",0,0,"Body processes G - Metabolic Phenomena G03",1,10,8,0,0,"Diabetes mellitus type 2"
"2014-001042-24-BE","2014-001042-24",1,1,"Diseases C - Virus Diseases C02",0,1976,NA,5,0.253036437246964,"Prophylaxis of Influenza"
"2014-001049-25-HU","2014-001049-25",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,291,8,0,0,"Treatment of type 2 diabetes mellitus T2DM with Inadequate Glycemic Control on Diet and Exercise"
"2014-001069-28-BE","2014-001069-28",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,13067,122,704,5.38761766281472,"Severe persistent Hypertriglyceridemia in High Cardiovascular Risk Patients"
"2014-001102-17-PL","2014-001102-17",1,1,"Body processes G - Metabolic Phenomena G03",1,461,10,0,0,"Type 2 Diabetes Mellitus"
"2014-001253-16-DE","2014-001253-16",0,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,40,16,0,0,"Type 2 diabetes mellitus"
"2014-001305-41-DE","2014-001305-41",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,179,NA,0,0,"Patients with type 2 diabetes and stable cardiovascular disease CVD and low grade inflammation"
"2014-001786-26-DK","2014-001786-26",1,1,"Diseases C - Hormonal diseases C19",1,90,4,0,0,"Type 1 diabetes and microalbuminuria."
"2014-001821-34-ES","2014-001821-34",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,813,60,1,0.1230012300123,"Diabetes mellitus type 2"
"2014-001922-14-BE","2014-001922-14",1,1,"Body processes G - Metabolic Phenomena G03",1,730,30,0,0,"Type 1 diabetes mellitus"
"2014-001969-27-DE","2014-001969-27",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Diabetes mellitus type 2"
"2014-002399-10-ES","2014-002399-10",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,1013,75,1,0.0987166831194472,"Type 2 diabetes mellitus"
"2014-002568-33-DE","2014-002568-33",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,777,37,0,0,"Diabetes Mellitus, Type 1"
"2014-002844-42-ES","2014-002844-42",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,505,NA,3,0.594059405940594,"Type2-Diabetes"
"2014-003053-34-DE","2014-003053-34",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,74,37,0,0,"Type 2 diabetes mellitus"
"2014-003502-33-SK","2014-003502-33",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,460,21,1,0.217391304347826,"Diabetes Mellitus"
"2014-003503-29-SK","2014-003503-29",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,694,41,6,0.864553314121037,"Diabetes Mellitus"
"2014-003583-20-DE","2014-003583-20",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,440,28,2,0.454545454545455,"Type 2 Diabetes Mellitus"
"2014-003621-18-ES","2014-003621-18",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,505,23,0,0,"Diabetes Mellitus, Type 2"
"2014-003721-18-DE","2014-003721-18",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,443,44,4,0.90293453724605,"Inadequately controlled Diabetes Mellitus Type 2."
"2014-004478-41-GB","2014-004478-41",1,1,"Diseases C - Female diseases of the urinary and reproductive systems and pregancy complications C13",0,596,1,3,0.503355704697987,"Intrahepatic Cholestasis of pregnancy"
"2014-004533-13-DE","2014-004533-13",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,151,6,0,0,"Type 2 diabetes mellitus"
"2014-004599-49-BE","2014-004599-49",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,813,48,1,0.1230012300123,"Type 1 Diabetes Mellitus"
"2014-004683-38-IT","2014-004683-38",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,188,1,0,0,"Type 2 Diabetes mellitus"
"2014-004850-32-ES","2014-004850-32",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,717,35,1,0.139470013947001,"Type 2 Diabetes Mellitus"
"2014-004938-25-ES","2014-004938-25",1,0,"Diseases C - Eye Diseases C11",1,463,80,17,3.67170626349892,"Diabetic macular edema DME"
"2014-005153-39-BE","2014-005153-39",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,782,42,2,0.255754475703325,"Type 1 Diabetes Mellitus"
"2014-005256-26-DE","2014-005256-26",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,975,95,1,0.102564102564103,"Patients with confirmed, insulin-dependent type 1 diabetes mellitus for at least 1 year"
"2014-005375-91-ES","2014-005375-91",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,1199,55,5,0.417014178482068,"Diabetes Mellitus, Type 2"
"2014-005525-13-ES","2014-005525-13",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,613,43,0,0,"Type 2 Diabetes Mellitus"
"2014-005639-15-IT","2014-005639-15",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,1010,53,7,0.693069306930693,"Diabetes Mellitus, Type 2"
"2015-000148-40-GB","2015-000148-40",1,0,"Diseases C - Nervous System Diseases C10",0,228,101,1,0.43859649122807,"Parkinsons disease"
"2015-000208-25-IT","2015-000208-25",1,1,"Body processes G - Metabolic Phenomena G03",1,151,14,0,0,"Type 2 Diabetes Mellitus"
"2015-000408-24-HU","2015-000408-24",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,154,6,0,0,"Type 2 diabetes"
"2015-000493-35-BE","2015-000493-35",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,80,5,0,0,"Partial lipodystrophy"
"2015-000620-28-BE","2015-000620-28",0,0,"Diseases C - Cardiovascular Diseases C14",0,994,263,2,0.201207243460765,"Hypercholesterolemia"
"2015-000799-92-BE","2015-000799-92",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,514,26,1,0.194552529182879,"Hypercholesterolemia"
"2015-000804-24-ES","2015-000804-24",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,321,NA,0,0,"Type 2 Diabetes Mellitus with Moderate Renal Impairment CKD 3A"
"2015-000950-39-BE","2015-000950-39",1,1,"Diseases C - Cardiovascular Diseases C14",1,7341,409,722,9.83517231984743,"Type II Diabetes Mellitus and Diabetic Kidney Disease"
"2015-000990-11-BE","2015-000990-11",1,1,"Diseases C - Cardiovascular Diseases C14",1,5658,378,469,8.28914810887239,"Type II Diabetes Mellitus and Diabetic Kidney Disease"
"2015-001047-36-DE","2015-001047-36",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1025,193,0,0,"Diabetes Mellitus, Type 1"
"2015-001351-71-DE","2015-001351-71",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1861,83,9,0.483610961848469,"Diabetes Mellitus, Type 2"
"2015-001596-48-ES","2015-001596-48",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,419,20,0,0,"Diabetes Mellitus, Type 2"
"2015-001611-12-BE","2015-001611-12",1,0,"Diseases C - Cancer C04",0,322,164,206,63.9751552795031,"Acute Myeloid Leukemia AML"
"2015-001702-33-ES","2015-001702-33",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,643,40,2,0.31104199066874,"Type 2 diabetes mellitus and inadequate glycemic control on a stable dose of metformin"
"2015-001709-15-BE","2015-001709-15",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1402,52,1,0.0713266761768902,"Type 1 Diabetes Mellitus"
"2015-001760-19-DE","2015-001760-19",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1699,721,67,3.94349617422013,"Type II diabetes"
"2015-001934-19-DE","2015-001934-19",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",0,412,23,1,0.242718446601942,"Dyslipidemia"
"2015-002084-42-ES","2015-002084-42",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,461,34,1,0.216919739696312,"Type 1 diabetes mellitus"
"2015-002095-24-ES","2015-002095-24",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,423,35,2,0.472813238770686,"Type 2 Diabetes"
"2015-002560-16-BE","2015-002560-16",1,1,"Diseases C - Digestive System Diseases C06",0,2477,164,47,1.89745660072669,"Nonalcoholic steatohepatitis"
"2015-002676-24-ES","2015-002676-24",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,445,26,2,0.449438202247191,"CKD3 patients with type 2 diabetes mellitus and albuminuria."
"2015-002868-17-ES","2015-002868-17",1,0,"Diseases C - Cardiovascular Diseases C14",0,2466,106,232,9.40794809407948,"Secondary Prevention of Major Cardiovascular Events cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke, and urgent revascularization in post MI cohort."
"2015-003511-37-PL","2015-003511-37",1,1,"Diseases C - Blood and lymphatic diseases C15",0,551,22,3,0.544464609800363,"severe hypertriglyceridemia fasting TG levels 500 mg/dL 5.65 mmol/L and 2000 mg/dL 22.60 mmol/L"
"2015-003563-10-ES","2015-003563-10",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,3182,NA,58,1.82275298554368,"Diabetes Mellitus, Type 2"
"2015-003955-23-DK","2015-003955-23",1,1,"Diseases C - Eye Diseases C11",1,NA,NA,NA,NA,"Diabetic Retinopathy and Sleep disorder"
"2015-003997-33-BE","2015-003997-33",1,1,"Diseases C - Cardiovascular Diseases C14",0,2608,1,267,10.2377300613497,"Atrial fibrillation AF is one cause of stroke.  Stroke rate is increased in patients with atrial high rate episodes AHRE, an early stage of AF as well, even if stroke rates are lower when compared to stroke rates in patients with diagnosed AF.  Prevention of stroke, systemic embolism or cardiovascular death in patients with AHRE but without diagnosed atrial fibrillation AF and in addition at least two stroke risk factors by intake of NOACs shall be investigated."
"2015-004122-33-DE","2015-004122-33",0,0,"Diseases C - Blood and lymphatic diseases C15",0,24,409,0,0,"This study will enroll subjects with transfusion dependent beta-thalassemia, who do not have beta0/beta0 genotype, defined by a history of at least 100 mL/kg/year of packed red blood cells pRBCs or  8 transfusions of pRBCs per year in the 2 years preceding enrollment."
"2015-004136-36-DE","2015-004136-36",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,2229,56,15,0.672947510094213,"Treatment of high cardiovascular risk patients heterozygous familial hypercholesterolemia HeFH and atherosclerotic cardiovascular diseases ASCVD with hyperlipidemia"
"2015-004224-59-CZ","2015-004224-59",1,1,"Diseases C - Immune System Diseases C20",1,458,29,0,0,"Type 2 Diabetes mellitus"
"2015-004353-40-DE","2015-004353-40",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,127,5,1,0.78740157480315,"Type 1 Diabetes Mellitus"
"2015-004382-83-ES","2015-004382-83",1,0,"Diseases C - Skin and Connective Tissue Diseases C17",0,156,16,0,0,"Actinic keratosis"
"2015-004711-21-BE","2015-004711-21",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,421,10,1,0.237529691211401,"Type 2 Diabetes Mellitus and Hypercholesterolemia/Mixed Dyslipidemia"
"2015-004768-12-CZ","2015-004768-12",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,528,25,2,0.378787878787879,"Diabetes Mellitus, Type 2"
"2015-004990-34-ES","2015-004990-34",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,743,56,2,0.269179004037685,"Type 2 Diabetes Mellitus T2DM"
"2015-005041-31-HU","2015-005041-31",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,72,2,0,0,"Diabetes mellitus type 2"
"2015-005042-66-IT","2015-005042-66",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1000,1,0,0,"Diabetes Mellitus Type 2"
"2015-005209-36-ES","2015-005209-36",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,819,23,1,0.122100122100122,"Diabetes Mellitus, Type 2"
"2015-005210-30-DE","2015-005210-30",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,711,25,8,1.12517580872011,"Diabetes Mellitus, Type 2"
"2015-005326-19-DK","2015-005326-19",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,324,10,3,0.925925925925926,"Diabetes Mellitus, Type 2"
"2015-005356-99-ES","2015-005356-99",1,1,"Diseases C - Hormonal diseases C19",1,2688,7,0,0,"Type 1 Diabetes"
"2015-005357-12-ES","2015-005357-12",1,1,"Diseases C - Hormonal diseases C19",1,1770,39,0,0,"Type II Diabetes Mellitus"
"2015-005358-36-ES","2015-005358-36",1,1,"Diseases C - Hormonal diseases C19",1,903,44,0,0,"Diabetes Mellitus, Type 1"
"2015-005385-38-BE","2015-005385-38",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,2150,128,8,0.372093023255814,"Non-Alcoholic Steatohepatitis NASH and fibrosis"
"2015-005406-11-DE","2015-005406-11",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,881,28,3,0.340522133938706,"Type 2 diabetes mellitus, inadequate glycaemic control"
"2015-005482-23-DE","2015-005482-23",1,1,"Diseases C - Virus Diseases C02",0,1200,56,0,0,"Prophylaxis of Influenza"
"2015-005532-18-DE","2015-005532-18",1,1,"Diseases C - Cardiovascular Diseases C14",0,NA,NA,NA,NA,"Critical Limb Ischemia CLI"
"2015-005593-38-BE","2015-005593-38",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,953,46,2,0.209863588667366,"Diabetes Mellitus, Type 2"
"2015-005619-33-DE","2015-005619-33",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,392,19,0,0,"Obesity"
"2015-005622-19-BG","2015-005622-19",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,703,15,0,0,"Diabetes Mellitus, Type 2"
"2016-000240-34-ES","2016-000240-34",1,1,"Diseases C - Cardiovascular Diseases C14",1,NA,NA,NA,NA,"Critical Limb Ischemia in patients with Diabetes Mellitus"
"2016-000361-22-DE","2016-000361-22",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,300,14,0,0,"Type 2 diabetes mellitus"
"2016-000669-21-DE","2016-000669-21",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,238,8,0,0,"Diabetes Mellitus Type 2, Type 2 diabetes mellitus"
"2016-000878-38-ES","2016-000878-38",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1088,65,3,0.275735294117647,"Diabetes Mellitus, Type 2"
"2016-000904-27-AT","2016-000904-27",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,301,10,0,0,"Diabetes Mellitus, Type 2"
"2016-000988-16-FR","2016-000988-16",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,730,31,3,0.410958904109589,"Diabetes Mellitus, Type 2"
"2016-000989-35-SE","2016-000989-35",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,786,32,1,0.127226463104326,"Diabetes Mellitus, Type 2"
"2016-001356-22-HU","2016-001356-22",1,1,"Diseases C - Nervous System Diseases C10",0,296,4,0,0,"Spasticity due to multiple sclerosis"
"2016-001518-39-PL","2016-001518-39",1,1,"Diseases C - Blood and lymphatic diseases C15",0,470,20,7,1.48936170212766,"Severe hypertriglyceridemia fasting TG levels 500 mg/dL 5.65 mmol/L and 2000 mg/dL 22.60 mmol/L and mild or moderate renal impairment."
"2016-001644-19-IE","2016-001644-19",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,525,3,3,0.571428571428571,"Gestational Diabetes Mellitus"
"2016-001800-49-HU","2016-001800-49",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,518,33,4,0.772200772200772,"Type 2 diabetes mellitus"
"2016-001801-17-SK","2016-001801-17",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,952,40,5,0.525210084033613,"Type 2 diabetes mellitus"
"2016-001803-22-ES","2016-001803-22",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,770,14,1,0.12987012987013,"Type 2 diabetes mellitus"
"2016-001804-43-HU","2016-001804-43",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,570,30,9,1.57894736842105,"Type 2 diabetes mellitus"
"2016-001857-42-DE","2016-001857-42",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,406,36,0,0,"Type 2 diabetes mellitus"
"2016-002013-21-ES","2016-002013-21",1,1,"Body processes G - Metabolic Phenomena G03",1,426,107,1,0.234741784037559,"Diabetes Mellitus Type 2"
"2016-002154-20-BE","2016-002154-20",1,1,"Diseases C - Cardiovascular Diseases C14",0,5636,172,464,8.23278921220724,"Left ventricular dysfunction following an acute myocardial infarction."
"2016-002225-10-IT","2016-002225-10",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,2,2,0,0,"type 2 diabetes"
"2016-002320-83-BE","2016-002320-83",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",0,15,208,0,0,"Early onset pro-opiomelanocortin deficiency obesity"
"2016-002580-34-ES","2016-002580-34",1,1,"Body processes G - Metabolic Phenomena G03",1,312,77,0,0,"Diabetes Mellitus Type 2 with renal imparement"
"2016-002639-14-DE","2016-002639-14",1,1,"Diseases C - Eye Diseases C11",1,671,27,16,2.38450074515648,"NonProliferative Diabetic Retinopathy"
"2016-002688-32-BE","2016-002688-32",1,1,"Diseases C - Virus Diseases C02",0,2178,84,1,0.0459136822773186,"Influenza"
"2016-002801-20-DE","2016-002801-20",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,1600,116,13,0.8125,"Diabetes Mellitus, Type 2"
"2016-002826-35-PL","2016-002826-35",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,507,33,4,0.788954635108481,"Type 2 diabetes mellitus"
"2016-003485-11-BE","2016-003485-11",1,1,"Diseases C - Cardiovascular Diseases C14",0,13965,1532,857,6.13677049767275,"Patients with, or at high risk for, cardiovascular disease CVD who are statin intolerant."
"2016-003611-35-DE","2016-003611-35",0,0,"Diseases C - Blood and lymphatic diseases C15",0,19,389,0,0,"This study will enroll subjects with transfusion dependent beta-thalassemia, who have a beta0/beta0 genotype, defined by a history of at least 100 mL/kg/year of packed red blood cells pRBCs or  8 transfusions of pRBCs per year in the 2 year preceding enrollment."
"2016-003818-26-ES","2016-003818-26",1,1,"Diseases C - Cardiovascular Diseases C14",1,NA,NA,NA,NA,"Reduction of cardiovascular events in patients with Type II Diabetes"
"2016-003980-21-ES","2016-003980-21",1,1,"Diseases C - Cardiovascular Diseases C14",1,NA,NA,NA,NA,"Critical Limb Ischemia in patients with Diabetes Mellitus"
"2016-004015-13-ES","2016-004015-13",1,0,"Diseases C - Cardiovascular Diseases C14",0,492,1,0,0,"High cardiovascular risk without previous cardiovascular event."
"2016-004084-39-DE","2016-004084-39",1,1,"Diseases C - Cardiovascular Diseases C14",0,268,2,0,0,"This study is to assess the efficacy of bempedoic acid 180 mg/day versus placebo in decreasing low-density lipoprotein cholesterol LDL-C when added to ezetimibe therapy in patients with high LDL-Cholesterol on Low Dose or Less than Low Dose Statins."
"2016-004591-22-AT","2016-004591-22",1,1,"Diseases C - Cardiovascular Diseases C14",0,476,15,3,0.630252100840336,"Myocardial infarction"
"2016-004691-22-DE","2016-004691-22",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,328,3,2,0.609756097560976,"Type 1 Diabetes"
"2016-004724-34-ES","2016-004724-34",1,1,"Diseases C - Blood and lymphatic diseases C15",0,NA,NA,NA,NA,"Newly diagnosed Acute Myeloid Leukemia patients"
"2016-004889-26-ES","2016-004889-26",1,1,"Diseases C - Hormonal diseases C19",1,787,50,10,1.27064803049555,"Type 2 diabetes mellitus Chronic kidney disease stage 3"
"2016-004906-32-ES","2016-004906-32",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,277,13,15,5.41516245487365,"Type 2 diabetes mellitus Chronic kidney disease stage 4"
"2016-004965-22-ES","2016-004965-22",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,576,21,0,0,"Diabetes Mellitus, Type 2"
"2016-005223-88-PL","2016-005223-88",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,171,2,0,0,"Type 2 Diabetes Mellitus"
"2017-000048-17-ES","2017-000048-17",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,222,7,0,0,"Diabetes Mellitus, Type 1"
"2017-000062-30-DE","2017-000062-30",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,111,49,0,0,"Type 1 Diabetes mellitus"
"2017-000091-28-DE","2017-000091-28",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,597,27,3,0.50251256281407,"Type 1 diabetes mellitus Type 2 diabetes mellitus"
"2017-000092-84-PL","2017-000092-84",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,400,NA,1,0.25,"Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus"
"2017-000349-30-NL","2017-000349-30",0,0,"Analytical, Diagnostic and Therapeutic Techniques and Equipment E - Therapeutic techniques E02",1,16,57,0,0,"Type 2 diabetes mellitus"
"2017-000376-28-GB","2017-000376-28",1,1,"Diseases C - Cardiovascular Diseases C14",0,71,3,0,0,"Chronic heart failure with reduced HFrEF and preserved ejection fraction HFpEF diagnosed at least 3 months prior to informed consent."
"2017-000420-95-ES","2017-000420-95",1,1,"Body processes G - Metabolic Phenomena G03",1,384,40,1,0.260416666666667,"Diabetes Mellitus Type 2"
"2017-000474-11-ES","2017-000474-11",1,1,"Diseases C - Digestive System Diseases C06",0,1575,123,13,0.825396825396825,"Compensated Cirrhosis due to Nonalcoholic Steatohepatitis"
"2017-000486-72-DE","2017-000486-72",1,1,"Diseases C - Skin and Connective Tissue Diseases C17",0,200,2,0,0,"Actinic keratosis AK"
"2017-000487-15-ES","2017-000487-15",1,1,"Diseases C - Cardiovascular Diseases C14",0,14124,67,505,3.57547436986689,"ST segment Elevation Myocardial Infarction STEMI"
"2017-000996-98-BE","2017-000996-98",1,1,"Diseases C - Cardiovascular Diseases C14",0,18037,NA,703,3.89754393746188,"Acute Coronary Syndrome"
"2017-001090-16-NL","2017-001090-16",1,1,"Not possible to specify",0,105,1,0,0,"Chronic kidney disease"
"2017-001333-88-LT","2017-001333-88",0,0,"Diseases C - Cancer C04",0,144,90,0,0,"Prostate Carcinoma"
"2017-001450-34-ES","2017-001450-34",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,576,319,1,0.173611111111111,"Type 1 diabetes mellitus"
"2017-001596-23-PL","2017-001596-23",0,0,"Diseases C - Cardiovascular Diseases C14",0,461,10,0,0,"Newly diagnosed and uncontrolled patients with essential arterial hypertension."
"2017-001651-31-GB","2017-001651-31",1,1,"Body processes G - Reproductive physiologi cal processes G08",0,33,1,0,0,"Nausea and Vomiting in pregnancy Hyperemesis gravidarum"
"2017-001819-36-BE","2017-001819-36",1,1,"Diseases C - Virus Diseases C02",0,1607,102,0,0,"Hepatitis B vaccination in healthy adults"
"2017-001846-90-DE","2017-001846-90",1,1,"Diseases C - Cardiovascular Diseases C14",0,1615,181,29,1.79566563467492,"Hypercholesterolemia"
"2017-002156-84-BE","2017-002156-84",1,1,"Diseases C - Virus Diseases C02",0,326,NA,0,0,"Influenza A Infection"
"2017-002374-39-ES","2017-002374-39",1,1,"Diseases C - Hormonal diseases C19",1,97,11,0,0,"Diabetes Mellitus, Type 1"
"2017-002449-31-DE","2017-002449-31",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,168,69,0,0,"Type 1 diabetes mellitus"
"2017-002644-32-BE","2017-002644-32",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,10577,775,492,4.65160253379975,"Type 2 diabetes mellitus Chronic kidney disease"
"2017-002954-35-ES","2017-002954-35",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,4073,297,114,2.79891971519764,"Type 2 diabetes mellitus"
"2017-002956-10-PL","2017-002956-10",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,907,70,1,0.110253583241455,"Type 2 Diabetes Mellitus"
"2017-002971-24-DE","2017-002971-24",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,6609,490,667,10.0922983809956,"Chronic Kidney Disease"
"2017-003219-20-ES","2017-003219-20",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,1738,87,13,0.747986191024166,"Diabetes Mellitus, Type 2"
"2017-003370-13-ES","2017-003370-13",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,883,34,2,0.226500566251416,"Patients with Type 2 Diabetes who have failed to achieve glycemic control with basal insulin and oral antidiabetic agentsOADs"
"2017-003414-10-ES","2017-003414-10",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1207,44,2,0.165700082850041,"1. Obesity 2. Diabetes Mellitus, Type 2"
"2017-003490-33-ES","2017-003490-33",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1842,193,11,0.597176981541802,"Type 2 Diabetes"
"2017-003510-16-BE","2017-003510-16",1,1,"Diseases C - Cardiovascular Diseases C14",0,1216,98,141,11.5953947368421,"Cardiovascular diseases"
"2017-003960-11-BE","2017-003960-11",1,1,"Diseases C - Eye Diseases C11",1,720,32,44,6.11111111111111,"diabetic macular edema"
"2017-004341-24-PL","2017-004341-24",1,0,"Diseases C - Nervous System Diseases C10",0,201,16,3,1.49253731343284,"The purpose of the trial is to assess the efficacy of Pragiola pregabalin and Dulsevia duloxetin in patients with PDPN, investigate the effect of Pragiola and Dulsevia on pain and on quality of life QOL, depression symptoms, cognitive functions, sleep quality and daytime sleepiness and assess the safety of Pragiola and Dulsevia in patients with PDPN."
"2017-004358-40-LV","2017-004358-40",1,1,"Diseases C - Eye Diseases C11",1,354,24,6,1.69491525423729,"Diabetic macular edema"
"2017-004707-43-BE","2017-004707-43",1,1,"Diseases C - Cancer C04",0,297,34,2,0.673400673400673,"Chemotherapy induced peripheral neuropathy"
"2017-004742-23-ES","2017-004742-23",1,1,"Diseases C - Eye Diseases C11",1,1132,48,38,3.35689045936396,"diabetic macular edema"
"2017-004754-42-BE","2017-004754-42",1,1,"Diseases C - Cancer C04",0,285,33,34,11.9298245614035,"Chemotherapy induced peripheral neuropathy"
"2017-004915-38-PL","2017-004915-38",1,1,"Diseases C - Bacterial Infections and Mycoses C01",0,2893,946,6,0.207397165572071,"Pneumococcal disease"
"2017-005104-10-ES","2017-005104-10",1,1,"Diseases C - Eye Diseases C11",1,937,82,50,5.33617929562433,"Diabetic Macular Edema DME"
"2017-005105-12-ES","2017-005105-12",1,1,"Diseases C - Eye Diseases C11",1,950,143,31,3.26315789473684,"Diabetic Macular Edema DME"
"2018-000468-27-PL","2018-000468-27",1,1,"Diseases C - Virus Diseases C02",0,12458,11,58,0.465564296034677,"Flu vaccination"
"2018-000539-29-BE","2018-000539-29",1,1,"Diseases C - Cardiovascular Diseases C14",0,9535,NA,109,1.14315679077084,"The occurrence of life-threatening, major, and critical organ bleeding, and, major arterial and venous thrombosis in patients undergoing noncardiac surgery. And for patients in the blood pressure management factorial, the occurrence of vascular death and major vascular events."
"2018-000677-77-BE","2018-000677-77",1,0,"Body processes G - Metabolic Phenomena G03",0,NA,NA,NA,NA,"overweight and obese women with polycystic ovary syndrome PCOS at risk for metabolic syndrome"
"2018-000757-49-BE","2018-000757-49",1,1,"Analytical, Diagnostic and Therapeutic Techniques and Equipment E - Surgical Procedures, Operative E04",0,1023,189,62,6.06060606060606,"QPI-1002 is being developed for prevention of acute kidney injury AKI in patients at risk for AKI following cardiac surgery and for reduction in the incidence and severity of delayed graft function after kidney transplantation."
"2018-000892-33-DE","2018-000892-33",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,41,16,0,0,"Type 1 Diabetes mellitus"
"2018-000918-38-SK","2018-000918-38",1,0,"Diseases C - Hormonal diseases C19",0,173,1,0,0,"Growth Hormone Deficiency in Children"
"2018-002371-18-ES","2018-002371-18",1,1,"Diseases C - Hormonal diseases C19",1,1467,37,0,0,"Diabetes Mellitus, Type 1"
"2018-002431-18-BE","2018-002431-18",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,200,24,0,0,"Overweight Obesity"
"2018-002590-22-HU","2018-002590-22",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,520,14,0,0,"Diabetes Mellitus, Type 2"
"2018-002618-11-ES","2018-002618-11",1,0,"Diseases C - Hormonal diseases C19",1,1995,91,60,3.00751879699248,"Diabetes Mellitus, Type 2"
"2018-002878-50-BE","2018-002878-50",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,3533,664,506,14.3221058590433,"Diabetes Mellitus, Type 2 Chronic kidney disease"
"2018-003096-35-ES","2018-003096-35",1,1,"Body processes G - Physiological processes G07",0,214,47,2,0.934579439252336,"Endogenous Cushing syndrome"
"2018-003141-42-BE","2018-003141-42",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,9650,1533,1105,11.4507772020725,"Diabetes Mellitus, Type 2"
"2018-003422-84-ES","2018-003422-84",1,0,"Diseases C - Hormonal diseases C19",1,1437,51,5,0.34794711203897,"Diabetes Mellitus, Type 2"
"2018-003834-34-AT","2018-003834-34",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,174,120,0,0,"Type 1 Diabetes mellitus"
"2018-004058-11-ES","2018-004058-11",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",0,104,49,0,0,"Obesity and hyperphagia in patients with Bardet-Biedl Syndrome or AlstrC6m syndrome"
"2018-004529-96-PL","2018-004529-96",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,959,47,3,0.312825860271116,"Diabetes Mellitus, Type 2"
"2018-004680-31-DK","2018-004680-31",1,0,"Diseases C - Hormonal diseases C19",1,216,167,0,0,"Type 1 and type 2 diabetes during pregnancy and lactation"
"2018-004926-26-BE","2018-004926-26",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,328,232,0,0,"Type 1 Diabetes T1D"
"2019-000860-99-ES","2019-000860-99",1,1,"Diseases C - Hormonal diseases C19",1,475,15,0,0,"Diabetes Mellitus, Type 2"
"2019-001004-37-SK","2019-001004-37",1,1,"Diseases C - Eye Diseases C11",1,1034,44,24,2.321083172147,"Diabetic Macular Edema"
"2019-001031-31-DE","2019-001031-31",1,1,"Diseases C - Eye Diseases C11",1,NA,NA,NA,NA,"diabetic macular edema"
"2019-001037-13-ES","2019-001037-13",1,1,"Diseases C - Cardiovascular Diseases C14",0,6463,NA,340,5.26071483831038,"Acute Myocardial Infarction"
"2019-001087-30-ES","2019-001087-30",1,1,"Diseases C - Digestive System Diseases C06",0,1082,50,2,0.184842883548983,"Moderately to Severely Active Crohns Disease"
"2019-002284-10-NL","2019-002284-10",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,103,15,0,0,"Healthy volunteers  Diabetes Mellitus, Type 2 Overweight Obesity"
"2019-003399-38-BE","2019-003399-38",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,791,25,13,1.64348925410872,"Peripheral arterial disease Diabetes Mellitus, Type 2"
"2019-003643-30-DE","2019-003643-30",1,1,"Diseases C - Eye Diseases C11",1,923,128,44,4.7670639219935,"Diabetic Macular Edema"
"2019-004956-12-DE","2019-004956-12",1,1,"Body processes G - Physiological processes G07",0,137,17,1,0.72992700729927,"Hypercortisolism"
"2020-000284-23-DE","2020-000284-23",1,0,"Diseases C - Hormonal diseases C19",1,1425,140,18,1.26315789473684,"Type 2 diabetes mellitus"
"2020-000299-39-DE","2020-000299-39",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,1602,62,9,0.561797752808989,"Diabetes Mellitus, Type 2"
"2020-000442-34-IT","2020-000442-34",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,984,52,9,0.914634146341463,"Diabetes Mellitus, Type 2"
"2020-000454-10-DE","2020-000454-10",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,525,26,4,0.761904761904762,"Diabetes Mellitus, Type 2"
"2020-000472-37-FR","2020-000472-37",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,587,38,3,0.511073253833049,"Diabetes Mellitus, Type 2"
"2020-000474-16-BE","2020-000474-16",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,582,47,3,0.515463917525773,"Diabetes Mellitus, Type 2"
"2020-000476-38-DE","2020-000476-38",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,1080,95,10,0.925925925925926,"Diabetes Mellitus, Type 2"
"2020-000664-31-SE","2020-000664-31",1,1,"Diseases C - Cardiovascular Diseases C14",0,3972,NA,70,1.76233635448137,"Acute Myocardial Infarction, Heart failure"
"2020-000753-28-BE","2020-000753-28",1,0,"Diseases C - Respiratory Tract Diseases C08",0,24972,3516,496,1.9862245715201,"Respiratory Syncytial Virus Infection"
"2020-000828-19-ES","2020-000828-19",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,106,4,3,2.83018867924528,"Diabetes Mellitus, Type 2 Chronic kidney disease"
"2020-000929-42-ES","2020-000929-42",1,1,"Diseases C - Hormonal diseases C19",0,259,24,0,0,"Adult Growth Hormone Deficiency AGHD"
"2020-001064-29-ES","2020-001064-29",1,1,"Diseases C - Eye Diseases C11",1,488,21,3,0.614754098360656,"Non-proliferative Diabetic Retinopathy NPDR"
"2020-001673-75-BE","2020-001673-75",1,1,"Diseases C - Virus Diseases C02",0,505,37,6,1.18811881188119,"Infection with SARS-CoV-2 virus, COVID-19 infection"
"2020-002374-27-DE","2020-002374-27",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,582,27,1,0.171821305841924,"Diabetes Mellitus, Type 1"
"2020-002542-16-DE","2020-002542-16",1,1,"Diseases C - Virus Diseases C02",0,581,15,40,6.88468158347676,"Subjects infected with SARS-CoV-2, admitted to hospital due to COVID-19"
"2020-003125-39-BE","2020-003125-39",1,0,"Diseases C - Cardiovascular Diseases C14",0,NA,NA,NA,NA,"Confirmed diagnosis of SARS-CoV-2  with symptomatic COVID-19 infection"
"2020-003170-44-BE","2020-003170-44",0,0,"Diseases C - Respiratory Tract Diseases C08",0,69,232,0,0,"Cystic Fibrosis"
"2020-003369-20-IT","2020-003369-20",1,1,"Diseases C - Virus Diseases C02",0,1627,24,0,0,"SARS CoV 2 infection in outpatients"
"2020-003510-12-DK","2020-003510-12",1,1,"Diseases C - Virus Diseases C02",0,562,51,1,0.177935943060498,"COVID-19"
"2020-004070-22-BE","2020-004070-22",0,0,"Diseases C - Virus Diseases C02",0,129,1,0,0,"Vaccination for prophylaxis of COVID-19 adults with co morbidities"
"2020-004170-22-ES","2020-004170-22",1,1,"Diseases C - Cardiovascular Diseases C14",1,616,57,16,2.5974025974026,"Heart failure with preserved ejection fraction Diabetes Mellitus, type 2"
"2020-005281-34-BE","2020-005281-34",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,1288,128,5,0.388198757763975,"Diabetes Mellitus, Type 2"
"2020-005308-21-SK","2020-005308-21",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,681,100,2,0.293685756240822,"Diabetes Mellitus, Type 2"
"2020-005309-18-DE","2020-005309-18",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,668,62,3,0.449101796407186,"Diabetes Mellitus, Type 2"
"2020-006082-11-DE","2020-006082-11",1,1,"Diseases C - Virus Diseases C02",0,NA,NA,NA,NA,"COVID-19"
"2021-000623-13-FR","2021-000623-13",1,0,"Diseases C - Virus Diseases C02",0,973,10,4,0.411099691675231,"Mild/moderate COVID-19"
"2021-000994-96-ES","2021-000994-96",1,1,"Diseases C - Respiratory Tract Diseases C08",0,367,35,2,0.544959128065395,"High risk pregnant women prevention of RSV-associated lower respiratory tract illnesses LRTIs in infants"
"2021-001194-24-BG","2021-001194-24",1,1,"Diseases C - Virus Diseases C02",0,199,214,48,24.1206030150754,"Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2 in Patients at High Risk for Acute Respiratory Distress Syndrome ARDS"
"2021-001501-69-SK","2021-001501-69",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,388,33,1,0.257731958762887,"Diabetes mellitus, Type 2"
"2021-001685-38-BE","2021-001685-38",1,1,"Diseases C - Hormonal diseases C19",0,452,14,0,0,"Moderate to Severe Vasomotor Symptoms Hot Flashes Associated with Menopause"
"2021-001909-77-BE","2021-001909-77",1,1,"Diseases C - Virus Diseases C02",0,1118,1,1,0.0894454382826476,"Prevention of Lower Respiratory Tract Disease Caused by The respiratory syncytial virus RSV"
"2021-002225-18-SE","2021-002225-18",1,NA,"Diseases C - Virus Diseases C02",0,757,469,4,0.528401585204756,"Respiratory Syncytial Virus Infection"
"2021-002569-16-ES","2021-002569-16",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,986,46,9,0.912778904665314,"type 2 diabetes mellitus"
"2021-002895-38-ES","2021-002895-38",1,1,"Diseases C - Virus Diseases C02",0,2091,3,15,0.717360114777618,"Coronavirus Disease 2019 COVID-19"
"2021-003612-31-FR","2021-003612-31",1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,196,7,0,0,"Type 2 Diabetes Mellitus T2DM"
"2021-004923-34-DE","2021-004923-34",1,1,"Diseases C - Virus Diseases C02",0,18348,164,75,0.408763897972531,"respiratory syncytial virus disease"
"2021-005065-40-NL","2021-005065-40",1,1,"Diseases C - Cardiovascular Diseases C14",0,2528,129,31,1.22626582278481,"dyslipidemia heterozygous familial hypercholesterolemia HeFH atherosclerotic cardiovascular disease ASCVD"
"2021-005878-25-ES","2021-005878-25",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,730,44,2,0.273972602739726,"Diabetes Mellitus, Type 2"
"2021-005891-21-GR","2021-005891-21",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",NA,928,88,3,0.323275862068966,NA
"2021-005892-38-PL","2021-005892-38",1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,692,39,1,0.144508670520231,"Diabetes Mellitus, Type 1"
"2021-006504-32-PL","2021-006504-32",1,1,"Diseases C - Virus Diseases C02",0,2085,NA,2,0.0959232613908873,"SARS-CoV-2 infection"
"2022-000623-21-BE","2022-000623-21",1,0,"Diseases C - Virus Diseases C02",0,1045,159,6,0.574162679425837,"Respiratory syncytial virus infection"
"2022-001981-36-ES","2022-001981-36",1,0,"Diseases C - Virus Diseases C02",0,1533,1,2,0.130463144161774,"Respiratory syncytial virus infection"
"2022-002741-18-ES","2022-002741-18",1,1,"Diseases C - Virus Diseases C02",0,465,NA,0,0,"Coronavirus disease 2019 COVID-19 in patients who have a high risk of developing serious or severe illness"
"2022-003124-41-BE","2022-003124-41",0,0,"Diseases C - Female diseases of the urinary and reproductive systems and pregancy complications C13",0,859,6,1,0.116414435389988,"Pregnancy related outcomes and events in maternal participants who were vaccinated against RSV or received control, and in their infants"
"2004-000140-25-GB",NA,1,1,"Unknown",0,NA,NA,NA,NA,"Prevention of systemic inflammatory response predominantly triggered by the interaction between the patients blood and the pumps artificial surfaces in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. This is manifested as an increase in mortality and myocardial infarction."
"2004-000441-38-IT",NA,1,NA,"Unknown",0,NA,NA,NA,NA,"Patient HIV-positivi with CD4350/mmc"
"2004-000573-54-IT",NA,0,NA,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2004-000703-18-ES",NA,1,1,"Unknown",1,NA,NA,NA,NA,"Essential hypertension with associated Diabetes Mellitus type 2."
"2004-002535-12-AT",NA,1,0,"Unknown",0,NA,NA,NA,NA,"elevated LDL-C"
"2004-004203-38-IT",NA,1,1,"Unknown",1,NA,NA,NA,NA,"DIABETES MELLITUS AND HYPERTENSION"
"2005-000091-40-GB",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Chronic Diabetic Foot Ulcers"
"2005-000604-14-ES",NA,1,1,"Unknown",1,NA,NA,NA,NA,"Diabetic Nephropathy Nefropata Diabtica"
"2005-001436-72-ES",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus"
"2005-002095-15-BE",NA,1,1,"Unknown",1,NA,NA,NA,NA,"Overt Type 2 Diabetic Nephropathy"
"2005-003158-91-BE",NA,1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetic Microalbuminuria"
"2005-004431-21-ES",NA,1,0,"Unknown",0,NA,NA,NA,NA,"Trasplante renal de donante cadavrico"
"2005-004589-18-ES",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus tipo 1 o tipo 2"
"2005-004626-10-DK",NA,1,0,"Unknown",0,NA,NA,NA,NA,"Smopking nicotine addiction/Tobacco addiction"
"2005-004775-38-DK",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Patients with type 1 diabetes"
"2006-000305-35-ES",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus type II"
"2006-000306-23-ES",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus type I"
"2006-000371-15-AT",NA,1,0,"Unknown",0,NA,NA,NA,NA,"Reithosen-Fettverteilungstyp an den Lateralseiten der Oberschenkel"
"2006-001035-22-ES",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Edema Macular diabetico"
"2006-001182-41-GR",NA,1,1,"Unknown",1,NA,NA,NA,NA,"Diabetic Macular Oedema"
"2006-001254-27-FR",NA,1,0,"Unknown",0,NA,NA,NA,NA,"Patients atteints de mucoviscidose, chez lesquels un diagnostic de diabte a t fait par hyperglycmie provoque orale HGPO"
"2006-001727-19-IT",NA,0,0,"Unknown",0,NA,NA,NA,NA,"exudative maculopathy"
"2006-002245-36-ES",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus tipo II  controlada de forma subptima con la combinacin de metformina y un secretagogo Type II diabetes Mellitus sub-optimally controlled on combination Metformin and a secretagogue."
"2006-002457-69-ES",NA,1,1,"Unknown",1,NA,NA,NA,NA,"Recent-onset type I diabetes mellitus T1DM Diabetes Mellitus tipo I de reciente aparicin"
"2006-002950-32-DK",NA,1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes diagnosed according to the criteria from WHO"
"2006-003055-20-IT",NA,1,0,"Unknown",1,NA,NA,NA,NA,"diabetes mellitus in pregnancy and iperinsulinism"
"2006-003101-53-DE",NA,1,1,"Unknown",0,NA,NA,NA,NA,"The metabolic syndrome constitutes a cluster of risk factors for cardiovascular disease with increased morbidity and mortality. The metabolic syndrome is referred to as a concomitant occurrence of hypertension, hyperlipidemia, impaired glucose tolerance with insulin resistance and abdominal obesity."
"2006-003371-13-BE",NA,1,1,"Unknown",0,NA,NA,NA,NA,"Crohns disease, NOS"
"2006-005127-42-DE",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes mellitus Type 2"
"2006-006034-18-DE",NA,1,1,"Unknown",0,NA,NA,NA,NA,"For treatment to reduce cardiovascular events associated with ischemic damage and/or ischemia-reperfusion injury in patients undergoing CABG surgery."
"2006-006328-20-GR",NA,1,1,"Unknown",1,NA,NA,NA,NA,"This study will evaluate the safety and efficacy of combined treatment with L- Carnitine and Simvastatin in reducing the Lipoprotein a and triglyceride level of patients with mixed hyperlipidemia. It can also include recently diagnosed patients wih diabetes mellitus type 2, who receive only dietary treatment. Lipoprotein a and hyperlipidemia are known risk factors for cardiovascular heart disease."
"2006-006543-31-DE",NA,1,1,"Unknown",0,NA,NA,NA,NA,"Subjects with active sight-threatening, non-infectious intermediate-, anterior and intermediate-, posterior- or pan-uveitis."
"2006-006544-66-DE",NA,1,1,"Unknown",0,NA,NA,NA,NA,"Subjects with clinically quiescent sight-threatening, non-infectious intermediate-, anterior and intermediate-, posterior- or pan-uveitis requiring systemic immune suppression."
"2006-006545-13-DE",NA,1,1,"Unknown",0,NA,NA,NA,NA,"Subjects with active sight-threatening, non-infectious anterior, anterior and intermediate- or panuveitis who require systemic immunosuppression for the control of their disease."
"2006-006599-39-DE",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus Type 1"
"2006-006600-11-DE",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus Type 2"
"2007-001493-91-NL",NA,1,1,"Unknown",0,NA,NA,NA,NA,"Healthy individuals at average risk, without a clear indication or contraindication to lipid lowering or blood pressure lowering with any of the study drugs. Women aged 65 and men aged 55, with one additonal CV risk factor for details: see Protocol, are eligible in the absence of documented clinically manifest atherothrombotic CVD, or other major illnesses expected to interfere with study paricipation."
"2007-002060-10-DE",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Type 1 and Type 2 Diabetes mellitus"
"2007-005899-13-BG",NA,1,0,"Unknown",1,NA,NA,NA,NA,"type 1 diabetes mellitus"
"2007-006084-73-DE",NA,0,0,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus Type 1"
"2007-006085-15-DE",NA,0,0,"Unknown",1,NA,NA,NA,NA,"Diabetes Mellitus Type 2"
"2008-001184-11-DE",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2008-003241-89-ES",NA,1,1,"Unknown",0,NA,NA,NA,NA,"Prevencin del rechazo agudo de aloinjertos en receptores adultos de trasplantes de rin de novo. Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients."
"2008-003636-38-ES",NA,1,1,"Unknown",1,NA,NA,NA,NA,"lceras crnicas del pie en pacientes con diabetes Chronic foot ulcers in patients with diabetes"
"2008-003698-42-ES",NA,1,1,"Unknown",0,NA,NA,NA,NA,"prevencin del ictus y de acontecimientos emblicos sistmicos en pacientes con fibrilacin auricular the prevention of stroke and systemic embolic events SEE in patients with non-valvular atrial fibrillation AF"
"2008-004916-12-DE",NA,1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus"
"2008-005453-38-DE",NA,1,0,"Unknown",0,NA,NA,NA,NA,"Patients with primary epithelial invasive carcinoma of the breast pT1-4, pN0-3, pM0"
"2008-006763-36-DE",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Patients suffering from diabetes mellitus type 1 or 2 with the indication for insulin treatment and dependent on insulin administration."
"2008-007176-22-DK",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Patients with type 1 diabetes"
"2009-010967-18-NL",NA,1,1,"Unknown",1,NA,NA,NA,NA,"patients with type 2 diabetes, failing on maximal oral glucose-lowering drugs, starting on insulin therapy in combination with standard metfromin 2 x 850"
"2009-013264-39-DE",NA,1,1,"Unknown",1,NA,NA,NA,NA,"Type 1 or Type 2 Diabetes Mellitus"
"2009-016384-11-FR",NA,1,1,"Unknown",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2009-016812-18-ES",NA,1,1,"Unknown",0,NA,NA,NA,NA,"Tratamiento de pacientes con sindrome coronario agudo Treatment of patients with acute coronary syndromes"
"2009-017686-34-ES",NA,1,1,"Unknown",1,NA,NA,NA,NA,"Pacientes con disfuncin erctil que presenten dislipemia, hipertensin, diabetes y/o obesidad."
"2009-017843-32-NL",NA,1,0,"Not possible to specify",0,NA,NA,NA,NA,"Liver transplantation"
"2009-018173-31-BE",NA,1,1,"Unknown",0,NA,NA,NA,NA,"To determine the impact of clonidine versus placebo and ASA versus placebo on the 30-day risk of all-cause mortality or nonfatal MI in patients with, or at risk of, atherosclerotic disease who are undergoing noncardiac surgery."
"2010-019501-41-DE",NA,1,0,"Diseases C - Blood and lymphatic diseases C15",0,NA,NA,NA,NA,"High Risk Polycythemia Vera or High Risk Essential Thrombocythemia"
"2010-021014-33-FR",NA,1,1,"Unknown",1,NA,NA,NA,NA,"Wound closure rate of diabetic foot ulcers DFUs of neuropathic origin."
"2010-021015-16-BE",NA,1,1,"Diseases C - Skin and Connective Tissue Diseases C17",1,NA,NA,NA,NA,"Wound closure rate of diabetic foot ulcers DFUs of neuropathic origin."
"2010-021977-35-ES",NA,1,0,"Unknown",0,NA,NA,NA,NA,"Neuropata diabtica dolorosa"
"2010-022304-50-SK",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Type 2 Diabetes"
"2010-022473-33-AT",NA,1,0,"Unknown",1,NA,NA,NA,NA,"Patients with macular edema due to diabetic retinopathy"
"2010-023433-35-FR",NA,1,1,"Unknown",0,NA,NA,NA,NA,"diabte type 2"
"2010-023839-42-CZ",NA,1,0,"Diseases C - Cardiovascular Diseases C14",0,NA,NA,NA,NA,"Patients with elective coronary artery bypass grafting with LV systolic dysfunction EF LV  50"
"2011-000439-10-IT",NA,1,1,"Diseases C - Hormonal diseases C19",1,NA,NA,NA,NA,"obese subjects with type 2 diabetes  and hypogonadism"
"2011-000619-16-ES",NA,0,0,"Body processes G - Cell Physiological Phenomena G04",1,NA,NA,NA,NA,"Hiptesis: el tratamiento con alopurinol 600 mg/da en pacientes diabticos resistentes a aspirina con enfermedad coronaria establecida podra favorecer el efecto antiplaquetario de la aspirina e inducir cambios en el perfil de expresin proteico de estas clulas Hypothesis: treatment with allopurinol 600 mg/day in diabetic patients resistant to aspirin with established coronary disease could enhance the antiplatelet effect of aspirin and induce changes in its protein expression profile"
"2011-004221-28-FR",NA,1,0,"Unknown",NA,NA,NA,NA,NA,NA
"2011-005344-95-DK",NA,0,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"type 2 diabetes"
"2011-006352-36-LT",NA,1,0,"Diseases C - Hormonal diseases C19",1,NA,NA,NA,NA,"The aim of our study is to establish the effectivenes and safety of metformin use in pediatric obese population to assess the prevalence of insulin resistance, metabolic syndrome, polycystic ovary syndrome PCOS, impaired glucose tolerance IGT and type 2 diabetes mellitus T2DM among overweight and obese children and adolescents in Lithuania, and to determine the effect of targeted interventions lifestyle and metformin in controlling obesity and associated diseases risk."
"2012-002219-25-ES",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 2 diabetes"
"2012-002526-67-DK",NA,1,1,"Diseases C - Hormonal diseases C19",1,NA,NA,NA,NA,"Type 1 Diabetes"
"2012-002856-18-BE",NA,1,1,"Body processes G - Metabolic Phenomena G03",0,NA,NA,NA,NA,"end-stage renal failure ESRF cardiovascular complication"
"2012-004100-35-ES",NA,1,0,"Diseases C - Hormonal diseases C19",0,NA,NA,NA,NA,"Ovarian hyperandrogenism"
"2012-005220-15-NL",NA,1,1,"Diseases C - Hormonal diseases C19",1,NA,NA,NA,NA,"type 2 diabetes mellitus"
"2012-005427-32-IT",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,NA,NA,NA,NA,"metabolic syndrome"
"2012-005841-19-DE",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Diabetic foot ulcers with mean diameter between 1.5 and 5 cm after dbridement if indicated wound stage Wagner grade I or II, Armstrong stadium A or C for Wagner-Armstrong-Classification, treated for at least 4 weeks unsuccessfully"
"2013-000418-39-ES",NA,1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Non diabetic hyperglycaemia: Impaired Glucose Tolerance IGT or Impaired Fasting Glucose IFG or both"
"2013-001764-35-DE",NA,0,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"TYPE 2 DIABETES"
"2013-001794-24-IT",NA,1,0,"Diseases C - Cardiovascular Diseases C14",1,NA,NA,NA,NA,"Patients with Acute Coronary Syndrome and Diabetes Mellitus"
"2013-001798-26-FR",NA,1,0,"Not possible to specify",0,NA,NA,NA,NA,"Kidney transplantation"
"2013-003481-14-DK",NA,1,1,"Diseases C - Hormonal diseases C19",1,NA,NA,NA,NA,"Type 1 diabetes, microalbuminuria or macroalbuminuria and mildly impaired kidney function."
"2014-001397-33-BE",NA,1,1,"Diseases C - Cardiovascular Diseases C14",0,NA,NA,NA,NA,"Device-detected sub-clinical atrial fibrillation"
"2014-001514-26-ES",NA,1,0,"Diseases C - Skin and Connective Tissue Diseases C17",0,NA,NA,NA,NA,"Patients with venous leg ulcers, between 40-100 years old, assigned to ten health centers in the county Ezkerraldea-Enkarterri Osakidetza Basque Health Service."
"2014-002285-76-DK",NA,1,1,"Diseases C - Hormonal diseases C19",1,NA,NA,NA,NA,"Type 1 Diabetes"
"2015-000239-34-ES",NA,1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"The purpose of this study is to evaluate the effect of high dose Renin-Angiotensin System RAS-antagonists and beta-blocker treatment for the primary prevention of cardiac events in a population of patients with Type 2 diabetes mellitus T2DM with no evidence of a preexisting cardiac disease."
"2015-000361-31-ES",NA,1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Gestational diabetes GD"
"2015-000915-42-FR",NA,1,0,"Diseases C - Hormonal diseases C19",NA,NA,NA,NA,NA,NA
"2015-000934-31-BE",NA,1,1,"Diseases C - Bacterial Infections and Mycoses C01",1,NA,NA,NA,NA,"Diabetic Patients with an Infected Foot Ulcer"
"2015-001501-14-FR",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Diabetic patient diabetes mellitus with hypertension associated with low renin"
"2015-002040-14-BE",NA,1,1,"Diseases C - Cardiovascular Diseases C14",1,NA,NA,NA,NA,"Secondary cardiovascular disease CVD prevention in type 2 diabetes mellitus T2DM subjects with low high-density lipoprotein cholesterol HDL-C at high risk for MACE."
"2015-002135-17-IT",NA,1,0,"Diseases C - Hormonal diseases C19",1,NA,NA,NA,NA,"Type 1 Diabetes Mellitus"
"2015-004164-11-IT",NA,1,0,"Diseases C - Cardiovascular Diseases C14",0,NA,NA,NA,NA,"Arterial hypertension"
"2015-005092-24-ES",NA,1,0,"Diseases C - Hormonal diseases C19",0,NA,NA,NA,NA,"ovarian hyperandrogenism with hyperinsulinaemia"
"2016-001165-88-NL",NA,1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 2 diabetes"
"2016-001401-16-NL",NA,1,0,"Diseases C - Female diseases of the urinary and reproductive systems and pregancy complications C13",1,NA,NA,NA,NA,"The medical condition to be investigated in this trial is gestational diabetes with insufficient glycemic control by means of dietary adjustments and thus an indication for addiotional pharmacological treatment."
"2016-001986-10-FR",NA,1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Pregnant women with Gestational Diabetes Mellitus GDM"
"2017-003455-35-BE",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 2 diabetes mellitus"
"2018-000833-12-IT",NA,1,0,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"type 2 diabetes mellitus"
"2018-000859-40-IT",NA,1,1,"Diseases C - Hormonal diseases C19",1,NA,NA,NA,NA,"Type-2 diabetes"
"2018-001616-30-ES",NA,0,0,"Body processes G - Physiological processes G07",0,NA,NA,NA,NA,"Endogenous Cushing Syndrome"
"2018-002406-32-FR",NA,1,1,"Diseases C - Cancer C04",0,NA,NA,NA,NA,"Indication of curative radiotherapy after conservative breast cancer surgery. Accepted scheme of  radiotherapy: 50 Gy main + 16 Gy on the tumoral bed supplement of dose."
"2018-002589-38-CZ",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Diabetes Mellitus, Type 2"
"2018-002952-34-BE",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Diabetes Mellitus, Type 2"
"2018-003022-89-GR",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"GUT-DERIVED INCRETIN HORMONES IN THE PATHOPHYSIOLOGY OF TYPE 1 DIABETES MELLITUS EFFECT OF METFORMIN TREATMENT"
"2019-002073-56-BE",NA,1,1,"Diseases C - Digestive System Diseases C06",0,NA,NA,NA,NA,"Nonalcoholic Steatohepatitis NASH"
"2019-002622-79-ES",NA,1,1,"Diseases C - Female diseases of the urinary and reproductive systems and pregancy complications C13",1,NA,NA,NA,NA,"Gestational Diabetes Mellitus"
"2020-000763-23-ES",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Type 2 Diabetes Mellitus with varying renal function from normal up to CKD3B"
"2020-001603-16-ES",NA,1,0,"Diseases C - Virus Diseases C02",0,NA,NA,NA,NA,"Adult patients over 70 years of age diagnosed by COVID-19 with outpatient follow-up"
"2020-001689-12-ES",NA,1,1,"Diseases C - Virus Diseases C02",0,NA,NA,NA,NA,"Men and women over 40 years of age, with a diagnosis of COVID-19 infection and at least one high risk criterion."
"2020-001723-13-FR",NA,1,0,"Diseases C - Virus Diseases C02",0,NA,NA,NA,NA,"COVID-19 patients with risk factor for poor outcome"
"2020-001926-71-BE",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"Recent onset Type 1 Diabetes"
"2020-002029-28-FR",NA,1,1,"Diseases C - Virus Diseases C02",0,NA,NA,NA,NA,"COVID-19 disease"
"2020-002609-24-ES",NA,1,1,"Body processes G - Bones and nerves physological processes G11",0,NA,NA,NA,NA,"Peripheral neuropathic pain"
"2020-003326-23-DE",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",1,NA,NA,NA,NA,"3. Diabetic foot ulcer treated unsuccessfully for at least 4 weeks with mean diameter between 1.5 and 4 cm after dbridement"
"2020-004393-22-ES",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,NA,NA,NA,NA,"Patients With Cardiovascular Disease or at High Risk for Cardiovascular Disease, on Stable Lipid-Lowering Therapy Requiring Additional Low-Density Lipoprotein Cholesterol Reduction"
"2021-001144-98-PL",NA,1,1,"Diseases C - Virus Diseases C02",0,NA,NA,NA,NA,"SARS-CoV-2 infection with one or more of the following symptoms: fever, cough, muscle aches, mild breathlessness, chest pain, diarrhea, nausea, vomiting, anosmia, lack of taste, sore throat, nasal congestion"
"2021-001247-27-ES",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,NA,NA,NA,NA,"Overweight and obese individuals at high risk of chronic kidney disease progression."
"2021-002871-20-ES",NA,1,0,"Diseases C - Nutritional and Metabolic Diseases C18",0,NA,NA,NA,NA,"Patients with atherosclerotic cardiovascular CV disease ASCVD or high risk of ASCVD who need additional LDL-C reduction"
"2021-004035-88-IT",NA,1,0,"Diseases C - Virus Diseases C02",0,NA,NA,NA,NA,"Patients with mild to moderate SARS-COV-2 infection."
"2021-006621-22-DE",NA,1,0,"Diseases C - Virus Diseases C02",0,NA,NA,NA,NA,"Clinically Vulnerable Individuals with Mild COVID-19"
"2021-006794-37-ES",NA,1,1,"Diseases C - Eye Diseases C11",0,NA,NA,NA,NA,"Thyroid eye disease TED"
"2022-000035-23-NL",NA,0,0,"Diseases C - Virus Diseases C02",1,NA,NA,NA,NA,"Coronavirus disease COVID-19 is an infectious disease caused by a newly discovered coronavirus. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness."
"2022-000289-16-BE",NA,1,0,"Body processes G - Physiological processes G07",1,NA,NA,NA,NA,"TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE"
"2022-000790-94-PT",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,NA,NA,NA,NA,"Obesity"
"2022-002235-60-PT",NA,1,1,"Diseases C - Nutritional and Metabolic Diseases C18",0,NA,NA,NA,NA,"Obesity"
